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Abstract 
 The skin is the largest organ and the main barrier between the environment and the 
internal organs. Therefore, it is constantly exposed to deleterious effects of solar radiation 
which might be exacerbated by photosensitizer compounds. These compounds are capable 
of absorbing radiation between 290 and 700 nm, causing dermal reactions, through 
phenomena known as photosensitivity. It is known that ROS generation is one of the 
mechanisms involved in photosensitivity events. Several in vitro methods have been 
developed to assess phototoxicity including the 3T3 neutral red uptake phototoxicity test 
(3T3 NRU-PT) which is conducted with mouse fibroblasts. However, when a compound is 
applied on the skin, it is firstly exposed to keratinocytes and therefore testing phototoxicity 
in a human keratinocyte cell line would be more appropriate for a feasible methodology.  
The aim of the present study was to implement a phototoxicity assay in a human 
keratinocyte cell line (HaCaT) based on the 3T3 Neutral Red Uptake Phototoxicity assay 
(3T3 NRU-PT), using a UVA/UVB Osram lamp, and to evaluate the phototoxic potential of 
a series of raw materials for cosmetic and pharmaceutical products with the developed 
methodology. A complementary aim was to perform preliminary tests regarding the 
implementation of a phototoxicity test using oxidative stress measures (total glutathione- 
tGSH- and reactive oxygen species –ROS- generation) as endpoints. In order to optimize 
the NRU-PT assay, some parameters were analyzed such as optimal cell density and the 
neutral red dye concentration and incubation time. The irradiation dose and temperature, 
and HaCaT sensitivity to radiation were also evaluated. For validation purposes, 
chlorpromazine, quinine and 5-methoxypsoralen (5-MOP) were used as positive controls 
while sodium lauryl sulphate, hexachlorophene and acetylsalicylic acid were used as 
negative controls. The ability of the test compounds to generate ROS was analyzed using the 
2',7'-dichlorodihydrofluorescein diacetate (DCFH-DA) probe assay after 24h compound 
exposures, following optimization of probe concentration and incubation time. Using the 
test conditions previously optimized, generation of ROS and tGSH were studied as putative 
predictors of phototoxic potential after irradiation. 
The radiation intensity recommended by the Organisation for Economic Co-operation 
and Development (OCDE) 432 guideline is 1.7mW/cm2, which corresponded to the 
irradiation obtained with the lamp positioned at 46.5cm height. The keratinocyte cell line 
was sensitive to UV exposure and irradiation times longer than 15 min were cytotoxic. A 
period of 10 min, corresponding to cell viability of 77 ± 2.94%, was established as the 
optimal irradiation time. The optimization of the NR assay demonstrated that the ideal 
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concentration of the NR was 50 µg/mL (with 3h incubation time) and HaCaT cell density of 
2×105 cell/well. For chlorpromazine, 5-MOP and quinine the calculated photo irritation 
factor (PIF) values were 23.30 ± 2.69, 78.8 ± 5.11 and 2.09 ± 0.85, respectively. Regarding 
negative controls, sodium lauryl sulphate and hexachlorophene PIF values corresponded to 
1.25 ± 0.53 and 1.03 ± 0.08, respectively and acetylsalicylic acid PIF could not be obtained. 
When analyzing the phototoxicity of a series of test compounds, all were found to be non-
phototoxic (PIF≥ 2) except the C. sativa extract that can be classified as a probable 
phototoxic (PIF=2.18 ± 0.42). Noteworthy, in some cases the PIF values could not be 
calculated and therefore the calculation of mean photo effect (MPE) should be performed 
for the elucidation of the phototoxic effect.  
Regarding ROS generation assay, the optimal cell density and the DCFH-DA 
concentration and incubation time were optimized. Therefore, 2x105 cells/well, a 
concentration of 50 µM DCFH-DA and 30min incubation time appear to be the ideal 
conditions to this assay, since the fluorescence signal was high enough to ensure 
appropriate sensitivity. None of the compounds showed a marked ability to generate ROS 
in HaCaT cells after 24h compound exposure. With respect to the implementation of a 
phototoxicity test using oxidative stress measures (tGSH and ROS generation) as endpoints, 
the exploratory study performed puts in evidence the complexity of this evaluation and the 
need for further optimizations tests.  
The modified neutral red assay developed here in was found to be a simple and reliable 
method for detecting phototoxic effects of reference agents and raw materials of topical 
formulations. Based on our data, the HaCaT-NRU-PT is a valuable in vitro model for the 
phototoxicity evaluation.   
Bruna Maciel 
vi 
 
Resumo 
A pele é o maior órgão do corpo e a principal barreira entre o ambiente circundante e os 
órgãos internos. Por isso, a pele está constantemente exposta à radiação solar podendo 
causar efeitos deletérios, que podem aumentar quando a exposição solar é combinada com 
compostos fotosensibilizadores. Estes compostos são compostos capazes de absorver 
radiação entre 290 e 700 nm, originando reações dérmicas num fenómeno denominado 
como fotossensibilidade. Está relatado que a formação de ROS é um dos mecanismos 
envolvido na ocorrência da fotossensibilidade. Muitos métodos in vitro têm sido 
desenvolvidos para avaliação da fototoxicidade, incluindo o ensaio 3T3 NRU-PT que é 
realizado em fibroblastos de rato. Contudo, quando um composto é aplicados na pele, 
primeiramente entra em contacto com os queratinócitos e assim, testes de fototoxicidade 
usando linhas celulares de queratinócitos humanos são metodologias viáveis. 
O objetivo da presente dissertação foi a implementação de um ensaio de fototoxicidade 
numa linha celular de queratinócitos humanos (HaCaT) baseado no ensaio 3T3 NRU-PT 
com uma lâmpada UVA/UVB (Osram) e utilizando o método assim desenvolvido, avaliar o 
potencial fototóxico de uma série de matérias-primas e produtos farmacêuticos. Um 
objetivo complementar foi a realização de testes preliminares para a implementação de um 
teste de fototoxicidade usando a determinação do stresse oxidativo (formação de tGSH e 
ROS) como endpoint. No que diz respeito à otimização do ensaio NRU-PT, alguns 
parâmetros foram analisados, tais como, a densidade celular ideal, concentração do corante 
NR e o respetivo tempo de incubação. A dose e temperatura da irradiação e a sensibilidade 
da HaCaT à mesma, foram também parâmetros avaliados. Para fins de validação, a 
clorpromazina, quinina e 5-MOP foram usados como controlos positivos, enquanto o lauril 
sulfato de sódio, hexaclorofeno e ácido acetilsalicílico foram usados como controlos 
negativos. A capacidade destes compostos para formar ROS foi analisada usando um ensaio 
com a sonda DCFH-DA depois de uma exposição de 24h com o composto. Para tal, uma 
prévia otimização da concentração da sonda e do seu tempo de incubação foi realizada. 
Usando as condições otimizadas anteriormente, a formação de ROS e tGSH foram 
estudadas como uma predição putativa do potencial fototóxico depois da irradiação. 
A intensidade de radiação recomendada na norma 432 da OCDE é 1,7mW/cm2, o que 
corresponde à radiação obtida quando a lâmpada é colocada a 46,5 cm de altura. A linha 
celular de queratinócitos mostrou-se sensível à exposição UV e tempos superiores ou iguais 
a 15 min demonstraram citotoxicidade. Assim, um período de 10 min que corresponde a 77 
± 2,94% de viabilidade celular foi estabelecido como o tempo de irradiação ideal. A 
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otimização do ensaio NR demonstrou que a concentração ideal de NR é 50 µg/mL (com um 
tempo de incubação de 3h) e uma densidade celular da HaCaT de 2x105 células/poço. Para 
a clorpromazina, 5-MOP e quinina os valores de PIF calculados foram 23,30 ± 2,69, 78,8 ± 
5.11 e 2,09 ± 0.85, respetivamente. No que diz respeito aos controlos negativos, os valores 
de PIF do lauril sulfato de sódio e hexaclorofeno foram 1,25 ± 0,53 e 1,03 ± 0,08, 
respetivamente e não foi possível obter o PIF do ácido acetilsalicílico. Quando foi analisada 
a fototoxicidade de uma série de compostos, todos se mostraram como não fototóxicos 
(PIF≥ 2), exceto o extrato de C. sativa que pode ser classificado como provavelmente 
fototóxico (PIF=2,18 ± 0,42). Deve ser levado em conta que em alguns casos o valor de PIF 
não pôde ser calculado e assim, o cálculo do MPE seria um importante fator para elucidar o 
efeito fototóxico destes compostos. 
Relativamente ao ensaio da formação de ROS, foram avaliados alguns parâmetros, como 
por exemplo, a densidade celular ideal, a concentração de DCFH-DA e o respetivo tempo de 
incubação. Assim, 2x105 células/poço, uma concentração de DCFH-DA de 50 µM e um 
tempo de incubação de 30 min aparentam ser as condições ideias para este ensaio, uma vez 
que o sinal da fluorescência é alto o suficiente para assegurar uma sensibilidade apropriada 
do ensaio. Nenhum dos compostos mostrou uma capacidade relevante para formar ROS 
depois de uma exposição de 24h aos compostos em células HaCaT. No que diz respeito à 
implementação de um teste de fototoxicidade avaliando a quantidade de stresse oxidativo 
(formação de tGSH e ROS) como endpoints, o estudo exploratório evidencia a complexidade 
desta avaliação e a necessidade de testes de otimização mais aprofundados no futuro. 
O ensaio de NR modificado desenvolvido nesta dissertação mostrou ser um método 
simples e confiável para detetar os efeitos fototóxicos dos referidos agente e matérias-
primas de formulação tópica. Além disso, com base nos nossos dados, o HaCaT NRU-PT é 
uma modelo in vitro mais realista para a avaliação da fototoxicidade. 
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1. Introduction  
1.1. Skin 
The skin is known as the larger organ of the body and the main barrier between the 
organism and the external environment (1). Its primary function is the defense of the 
organism against pathogens invasion, minimizing chemical and physical aggressions, 
preventing this way an unregulated loss of water and solutes (2). Skin is also responsible for 
thermoregulation as it is a highly irrigated organ (3). 
Defined as an optically heterogeneous medium, skin controls the amount of radiation 
that can penetrate and reach the deepest dermal structures by mechanisms of reflection, 
refraction, scattering and absorption (4, 5). However, changes in its optical properties can 
result in a greater ultraviolet (UV) penetration, increasing the dose that reaches the viable 
skin layers (4), thus promoting skin damage (4, 6). 
The skin is divided in three different layers (Figure 1). The most external layer is 
denominated by epidermis. The middle layer is the structural component of the skin, the 
dermis. The inner layer, the hypodermis is composed by adipocytes, representing a support 
of fat between the skin and the organs (1). These layers will be described briefly in the 
following sections. 
 
Figure 1. Skin structure, highlighting the layers, cells, arteries, venules and other components (7). 
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1.1.1. Epidermis  
The epidermis corresponds to the outermost skin barrier (2). For that reason it is where 
topical products are applied. Its thickness is thus an important factor in photosensivity 
study and it may vary from 0.5 mm on the thinnest areas, such as eyelids, to 4-6 mm on the 
thicker ones, such as the palm of the hand and the sole of the foot. After skin contact, 
chemicals can penetrate the cutaneous barrier, and at the application point, the absorption 
is directly proportional to the thickness of the skin (1). 
 The epidermal layer is a stratified, squamous, keratinized and avascular tissue of 
ectodermal origin, that contains epithelial cells in five morphologically distinct layers, 
which are named, according to the direction dermis-epidermis: basal layer, spinous layer, 
granular layer, lucid layer and stratum corneum (Figure 2) (8). 
 
Figure 2. Structure of epidermis deficting the layers, the cells and the direction of development (9). 
 
The highest metabolic activity is found in the basal layer, where calls present high mitotic 
rate, which is important to produce enough cells to replace surface cells, as these are 
continually lost by desquamation (1, 10). 
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Figure 3. Histological section of human skin epithelium (11). 
 
The most abundant epidermal cells are the keratinocytes (1), corresponding to 90% of its 
cells (12). Keratinocytes owe their name to the fact that they produce "keratin" (1), a protein 
responsible for maintaining the epidermis integrity (1), since their chemical structure 
provides water resistance (12), making the epidermis impermeable to some chemical 
contact with the skin and resistant to environmental attacks (1). Melanocytes, Langerhans 
cells and Merkel cells are the other cells present in this layer (Figure 3) (1, 12). 
 
Skin oxidative stress 
It is known that the skin is constantly exposed to environmental damage, undergoing 
reactive oxygen species (ROS) generation and consequently oxidative stress, which may 
lead to cellular death and related skin diseases (13). As the keratinocytes are the most 
external barrier of the skin (1), they act as the main environmental barrier, defending the 
skin against damage such as UV radiation, bacteria, viruses, heat, parasites and fungi (13).  
ROS include the oxygen radicals (superoxide and hydroxyl) and the non-radical 
molecular oxygen derivatives (hydrogen peroxide and singlet oxygen) (14, 15). The cells 
have the capacity to generate ROS, especially in mitochondria, reducing molecular oxygen 
through nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and xanthine 
oxidase (16). It is known that ROS production in keratinocytes is stimulated by sunlight 
radiation (13), through NADPH oxidase and cyclooxygenase (COX) (17, 18). The NADPH 
quinone reductases have high activity in epidermis (19), increasing their rate when exposed 
to UV light (20) and the reduction on proteasome activity in human keratinocytes is also 
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associated with UV radiation (21). However, the elucidation of the cellular and molecular 
mechanisms involved in ROS generation in the skin warrants further research (22). 
The skin has several antioxidant defenses against ROS (10, 13, 23), including glutathione 
(GSH), superoxide dismutase (SOD), catalase, glutathione peroxidase-1 (GPx-1), 
metallothionein-2 (MT-2) (10), NADPH quinone oxidoreductase 1 (NQO1), and the phase 2 
enzyme heme oxygenase-1 (HO-1) (13, 23, 24). GSH is the major cellular antioxidant and 
participates in an enzymatic system that is capable of eliminating hydrogen peroxide. In live 
cells, 98% of the GSH pool remains in the reduced state due to glutathione reductase (25, 
26) (22), and the intracellular levels of GSH determine the cell capacity to cope with 
oxidative stress (25, 26). 
 
1.1.2. Dermis  
Dermis is the tissue that supports the skin and its appendages, such as hair, nails, etc. 
Furthermore, it is highly innervated and vascularized, in opposite to the epidermis (1). 
The dermis is divided into two layers: the most superficial, the papillary dermis (27), 
which has a rich capillaries network, providing nutrients for the overlying epidermis and 
skin appendages (1); and a thick bottom layer, the reticular dermis (27), composed of 
connective tissue a large collagen fiber, supporting the skin (1). 
The main cells of the dermis are the fibroblasts (1, 27) which are responsible for the 
synthesis of connective tissue components of the dermis, namely collagen, elastin, 
structural glycoproteins and glycosaminoglycans (27). In the dermis, mast cells, 
lymphocytes, and histiocytes, which are associated with the immunosystem, can also be 
found (Figure 4) (1). 
 
Figure 4. Structure of dermis, deficting the presence of connective tissue and blood vessels in reticular 
dermis (28). 
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1.1.3. Hypodermis 
The hypodermis is composed of adipocytes, grouped into "lobes", which are separated by 
connective tissue. It has arterioles and venules to easily nourish the hypodermis (1). In 
addition to the adipocytes, macrophages and fibroblasts are also present in this layer (29). 
The hypodermis serves as a "cushion" of fat between the skin and the organs that lie 
underneath (1), serving also as support to the other skin layers (29).  
 
1.2. Solar radiation 
Sunlight emits in all electromagnetic spectrum: X-rays, UV, visible light (vis), infrared 
and radio waves (in small amounts) (30). The most probable wavelengths to cause 
phototoxicity are the UV and the vis (31). The first wavelength is between 100nm-400nm, 
subdivided into ultraviolet A (UVA-315-400nm (23, 24)), ultraviolet B (UVB- 280-315nm 
(23, 24)) and ultraviolet C (UVC- 100-280nm (23, 24)) (3, 32) and the second comprises 
wavelength from 400 nm to 760 nm (33), the latter corresponding to the peak of radiation 
power that reaches the Earth surface (Figure 5) (30).  
 
 
Figure 5. Solar spectrum is divided into UV (UVA, UVB and UVC), visible light, infrared and x-rays (34). 
 
It is known that UV exposure is potentially dangerous to health. UVA affects directly the 
dermis leading to photoaging and DNA damage, inducing ROS generation (35, 36). Besides 
this, it represents the larger responsible for the phototoxic and photoallergic reactions (31, 
37). This fact is due to several reasons, such as: 95% of UV radiation that reaches the Earth 
surface corresponds to UVA (32);  it penetrates the skin more easily and has the capability 
to pass through many materials, including some windows (37). Regarding UVB radiation, 
sunburn is the most probable phototoxic reaction to be caused by UVB (32, 35), although 
only 5% of it can penetrate the ozone layer of the earth’s atmosphere (32). UVC is almost 
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completely absorbed by stratospheric ozone, so there is no evidence that it causes 
phototoxic reactions (31).  
Ultimately, visible light represents 50% of sunlight that arrives the Earth surface (3) 
easily penetrate the skin, although it is not energetic enough to cause severe damages. The 
reactions induced by visible light goes beyond the damage caused to the skin, such as eyes 
injuries and aging of the eye due to oxidative stress in the tissue (31). 
 
1.3.  Photosensitivity 
Photosensivity corresponds to the photobiology study of the cutaneous reaction (38). 
Photobiology studies the effects of UVA, UVB, visible and infrared (IR) radiation on living 
systems (39). For a photosensitivity reaction to occur, a photochemical event must occur. 
This event happens when UV/vis light is absorbed (40) by endogenous or exogenous 
chemicals (3), called photosensitizers (41). A photosensitizer is a chemical capable of 
entering the body through ingestion, injection, topical application (36, 41) or inhalation (36, 
42), and transferring energy to the cellular components (3). Furthermore, according to the 
Center for Drug Evaluation and Research (CDER), for a compound to be photoactivated it 
should absorb radiation between 290 and 700 nm (4). 
When a photoactivated compound, capable of reaching the skin by dermal penetration 
or through the systemic circulation, is applied and subsequently excited by UV or visible 
light, photoirritation, photoallergy, (4) photogenotoxicity or/and photocarcinogenicity 
phenomena (41) can occur (4). Further, eyes can also suffer ocular injury after being 
irradiated, resulting in oxidative stress (3, 43). 
 
1.3.1. Phototoxicity/photoirritation 
Phototoxicity is the most common manifestation of photosensitivity (44). The difference 
between phototoxicity and photoirritation is inconsistent (3) but most authors consider it 
the same (45, 46). Therefore, phototoxicity is characterized by an induction or enhancement 
of an acute response, independent of the immune system, after topical or systemic 
photosensitizer administration, which will reach the skin and subsequently be exposed to 
UV/vis radiation (4, 41, 45, 47, 48). Thus, it can be concluded that chemicals that absorb 
light in UV/vis region may cause phototoxicity if they absorb energy and produce ROS 
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(including singlet oxygen), or change to more toxic species (49, 50). Ultimately, 
phototoxicity reactions depend on several  factors, such as the radiation dose and the 
concentration of the photosensitizer (47) and it can be induced by a single exposure, not 
requiring an induction period (4, 47, 50).  
 
Clinical manifestations of phototoxicity 
The phototoxic reaction is, usually, associated with immediate symptoms (41), so it is 
possible to detect effects minutes to hours after exposure to a photosensitizer and UV/vis 
radiation (51). 
The phototoxic reaction symptoms depend on the photosensitizer and radiation doses 
that reach the skin and can vary from asymptomatic phase to serious sunburn (51). The 
most exposed areas to the sun, such as the nose, forehead, ears, V area of the neck and back 
of hands are the first to present symptoms, usually an exaggerated sunburn, followed by 
erythema, edema (51-53), blistering and prolonged hyperpigmentation (52). Vesicles and 
blisters appear in more severe reactions (51) with subsequent peeling (41, 50). Sometimes, 
similar signs of porphyria, such as the fragility of the skin and vesicles may appear as well 
as eczematous characteristics or lichenoid features (Table 1) (41, 50).  
 
Table 1. Main clinical manifestations of phototoxicity (51, 53). 
 
Acute phototoxicity Subacute phototoxicity Delayed phototoxicity 
Similar to exaggerated 
sunburn 
Pseudoporphyria 
Chronic actinic 
dermatitis 
Urticaria Photoonycholysis 
 
Erythema Dyschromia 
Edema Lichenoid features 
Tingling 
Eczematous 
characteristics 
Burning Telangiectasia 
Residual hyperpigmentation Pellagra 
Exfoliation Phytophotodermatitis 
Fever  
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1.3.2. Photoallergy 
Contrary to phototoxicity, photoallergy is defined as an immune reaction to a UV/vis 
radiation activated chemical (4, 45) having an idiosyncratic response. However, 
photosensitizers that cause a phototoxicity reaction can also cause a photoallergic reaction 
(4). Since the photoallergic reaction is an immune reaction (4, 45), it does not occur in the 
first exposition, requiring an induction period of one or two weeks before the skin reactivity 
becomes remarkable (4, 41). For this reason, photoallergy is usually defined as a delayed 
photosensitivity reaction (50). 
 
1.3.3. Photogenotoxicity/photomutagenicity 
Photogenotoxicity, or photomutagenicity, is a genotoxic response (41, 45) observed after 
the exposure to a photosensitizer and UV/vis radiation (41), that cause damage in the 
genetic information and consequently the formation of mutations (45, 54). This damage can 
affect the somatic and germ cells and this way it may transmitted to future generations (54). 
 
1.3.4. Photocarcinogenicity 
Photocarcinogenicity can occur when an organism is exposed to a chemical and repeated 
exposure to light/UV radiation (3, 41), inducing tumors (45). This can be due to two types 
of photocarcinogenicity: the photo co-carcinogenicity, which is an indirect increase of 
carcinogenic effects induced by UV, and the photochemical carcinogenesis, which is a 
carcinogenic effect of a drug when photoactivated by exposure to UV (41, 45). 
 
1.4. Mechanisms of photosensitivity reactions 
As mentioned above, all photosensitizers absorb in 290-700 nm range, which indicates 
the ability to a molecule become in excited state (41), i.e., the ability of a molecule to pass 
from the ground state to excited electronic state (3, 31). This change in molecules state can 
occur by two mechanisms: oxygen-dependent or not-dependent (3, 47). In oxygen-
dependent  processes, denominated type II reactions, the energy  is transferred to oxygen, 
producing a singlet oxygen (3), an excited molecule that can react with unsaturated fatty 
acids, nucleic acids molecules, proteins (47), plasma or membranes organelles (3) and 
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dissipate energy in several ways, such as by photolysis or photodegradation, originating 
toxic photo products (Figure 6) (41). In type I reaction (not-oxygen dependent mechanism), 
the transfer of electrons originates radicals which can, or not, involve oxygen (41, 44). When 
the energy transfer happen between biomolecules, photosensitizer and oxygen, ROS 
formation is induced (41, 55) which is the cause of most photosensitizers (56, 57). Since ROS 
are unstable and highly reactive molecules, when these molecules capture electrons from 
another molecules or biomolecules (DNA, proteins or lipids) they became stable but lead to 
oxidative damage and endogenous antioxidant system dysfunction, promoting skin damage 
(Figure 6) (58, 59). 
 
Figure 6. Mechanisms involved in photosensitivity (41). 
 
When the excited singlet state or the excited triplet state transfers energy to another 
molecule, light emission (fluorescence or phosphorescence) and/or heat release occur 
(Figure 7) (3, 31). The singlet state is usually short-lived (10-8 to 10-9 s), however, it can cross 
to form a triplet state, which has a longer lifetime (10-4 to 101 s) (31, 41). Generally, 
photosensitized oxidations proceed in the triplet state, thus, the most powerful 
photosensitizers are those that provide a high yield of a long-lived state (41). Triplet state 
has a sub-millisecond lifetime, so the photosensitization process is more powerful if the 
photosensitizer is excited close to the biological target (31, 41) or if, before absorption of 
light, it is formed a complex between the chromophore and the target (31).  
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Plasma membrane, cytoplasmic organelles and nucleus are the most probable cellular 
targets for photosensitizing oxidation, depending on the radiation absorption and 
photosensitizer location (41). The phototoxic potential of a compound depend of several 
factors, such as photosensitizer chemical nature, substrate chemical nature, light 
absorption (31, 41), excited states nature (3), reaction conditions (solvent, pH, 
photosensitizer concentration, substrate and oxygen), among others. (31, 41).  
 
Figure 7. Scheme demonstrative of energy states involved in mechanisms of phototoxicity (3).  
 
At histological level sunburn cells (SBC) are formed (60), which are apoptotic 
keratinocytes (61) that appear 24-48 hours after UVB irradiation (62) and can persist during 
1 week or more. However, this phenomenon is still poorly understood (3). 
 
1.5. Photosensitizers   
A photosensitizer is a chemical capable to absorb radiation between 290 and 700nm 
causing damage in living organism. A large number of photosensitizers has been recognized 
as industrial or therapeutic agents (41) forming part of plants, foods, pharmaceutics or 
cosmetics composition (47, 59). Regarding pharmaceutical products, a photosensitizer can 
be the drug itself, an excipient, a metabolite, an impurity or a degradation product (4). The 
photosensitizers have differences in their structures, with only one common aromatic 
system and/or conjugated multiple bonds (47). 
The vehicles used in the pharmaceutical and cosmetic industries have been reported with 
capacity to modify the optical properties of the skin (4), increasing, for example, the 
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cutaneous absorption of drugs (63, 64), reducing/increasing the amount of light reflected/ 
scattered/absorbed in the skin (4, 65, 66) or modifying drugs photoproperties (67, 68) and 
their photostability (4, 69-71). Besides that, the photosensitizer can still be photosensitizers 
by themselves (4, 72). 
In addition to drugs and cosmetic ingredients, certain proteins and environmental 
pollutants were described to have photosensitizer potential. Hereupon, photosensitizers are 
present in everyday life and the living organism can be exposed by several routes, so it 
becomes important to implement photosafety studies in several fields such as food, 
pharmaceutical and cosmetic industries and ecology (47). 
Since, cosmetics and medicines are possibly the best known photosensitizers and 
responsible for most phototoxicity reactions, they will be described in more detail below. 
 
1.5.1. Cosmetics 
A cosmetic product is any substance or preparation for topical application, either in the 
epidermis, hair, nails, lips, the external genitals or teeth and mucous membranes of the oral 
cavity, that is used to clear, perfume or protect them (73). 
It is known that cosmetics frequently cause adverse reactions, but not very severe health 
hazard (36). Nevertheless, the risks that cosmetic products carry to health must have special 
attention in chronic exposure and application over a large area of the skin (36, 59). Some 
cosmetics are referred to cause phototoxic reaction due to the active ingredients, fragrances 
and stabilizers. To assess the safety of cosmetics products, an important factor is how it is 
used the substance amount and concentration used, and the penetration rate. Some may 
contain “penetration enhancers”, which increase the skin penetration (36). Therefore, it is 
extremely important to ensure their photosafety as much as possible, creating regulations 
for cosmetic products (59, 74). Examples of cosmetic ingredients known to be phototoxic 
are 5-methoxypsolaren (5-MOP, bergapten) (3, 75, 76), 8-methaxypsolaren (xanthotoxin; 
8-MOP) (3, 75), angelicin (77).  
 
Sunscreens 
Sunscreens are considered cosmetic products in most countries and their use is an 
effective and inexpensive solution for preventing the skin damage induced by UV radiation 
(78). Since, they are in constant exposure to sunlight, they should not contain phototoxic 
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active ingredients (79) (which normally are the UV-filters (80)). For this reason, 
phototoxicity test must also be performed in sunscreens final formulation (79). 
Therefore, the cosmetic industry has made many efforts to develop sunscreens with a 
large absorption spectrum and few chemicals, since the presence of different UV filters can 
lead to synergistic effects in the sunscreens final performance and photostabilization (35). 
More and more UV filters and other active antioxidant substances as vitamin A derivatives 
have been found in the environment, which promote recovery and protection of 
photodamaged skin (81). Besides that, some UV-filters or combinations can be 
photodegraded, resulting in photo-products that can be toxic (35, 81). Thus, the study of the 
phototoxic potential of new UV-filters combinations and antioxidant substances is a priority 
(81). Due to their presence in environment, bioaccumulation and toxicological properties, 
including the photo-reaction, UV-filters have been considered as potentially harmful 
pollutant and it is mandatory to use stable UV-filters under UV exposure. Therefore, the 
study of UV-filters photostability, including photodegradation and phototoxicity is crucial 
(82). 
 
1.5.2. Drugs 
A drug is defined as a compound used to diagnose, cure, mitigate, treat or prevent a 
disease and to affect the structure or any function of animals or human’s body (83). A list 
with many different classes of drugs implicated in skin photosensitivity phenomena in 
humans was created in 2002 (Table 1) (47, 50, 84, 85). 
 
Table 2. Photosensitizer drugs (52). 
 
Antibiotics 
Fluoroquinolones 
Nalidixic acid 
Tetracyclines 
Sulphonamides 
Antifungals Griseofulvin 
Diuretics and cardiovascular agents 
Thiazides 
Frusemide 
Amiodarone 
Quinidine 
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The most common mechanism of drug-induced photosensitivity is, undoubtedly 
phototoxicity (50), which may require a metabolic conversion to become photoactive (3). 
However, some drugs can cause photosensitivity that does not involve UV absorption 
through the formation of endogenous molecules that absorb UV via secondary mechanisms 
(e.g. disruption of heme synthesis) (4).  
 
1.6. Photosafety evaluation 
The principal features that characterize a photosensitizer and support the 
recommendation to be submitted to photosafety testing  are:  ability to absorb radiation in 
the range of natural sunlight (290-700 nm) (4, 45, 57); capacity to generate reactive species 
following UV/vis absorption and distribution in a relevant degree to light-exposed tissues  
namely skin and eyes (57). In accordance with the Organisation for Economic Co-operation 
and Development (OECD), prior to in vivo or in vitro biological testing, the absorption 
spectrum in the UV/vis range should be determined for the substance in study (41, 48), 
which corresponding to the first step of photosafety tests (4, 45, 57). Preclinical photosafety 
tests serve to support clinical studies (86) and to determine if effects such as phototoxicity, 
photoallergy, photogenotoxicity or photocarcinogenesis are produced or improved by the 
presence of chemical and sunlight simulated radiation (Figure 8) (45). These tests should 
be performed only in vitro for cosmetics and in vitro or in vivo for drugs (86, 87). For most 
Non-steroidal anti-inflammatory 
drugs 
Naproxen 
Tiaprofenic acid 
Piroxicam 
Azapropazone 
Calcium channel antagonists 
Nifedipine 
Benoxaprofen (now discontinued) 
Psoralens 
8-MOP 
5-MOP 
Psychoactive drugs 
Phenothiazines  
(chlorpromazine, thioridazine) 
Protriptyline 
Retinoids 
Isotretinoin 
Etretinate 
Acitretin 
Photodynamic therapy agents 
Foscan 
Photofrin 
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pharmaceuticals, it is usually recommended that only the drug (not excipients) undergo 
testing for adverse photoeffects. However, for topical products which will be applied to the 
sun-exposed skin, Food and Drug Administration (FDA) recommends that the active 
ingredient and the drug product must be subjected to evaluation under conditions of 
simulated solar light (4). For ocular phototoxicity evaluation, there are no specific in vitro 
assays, and therefore the only possible conclusion is to consider the compound with little 
risk of being phototoxic (57). 
 
Figure 8. Hazard identification of photosensitivity (41). 
 
Some animal tests are allowed, but the main goal of the current research is the 
development and validation of 3Rs principles (Replace, Reduce and Refine) - alternative 
methods to animals use (88). The principles of the 3Rs advice researchers to use alternative 
or to upgrade the animal experiment conditions. The first R relates to the Replacement of 
the animal model. If this is not possible, researchers should consider the refining 
(Refinement) of the experiment, using, for example, anti-pain medication before and after 
the operation, better housing, better management conditions of the animals before 
experiments, reducing stress on-experiment. Finally, the last R (reduction) refers to the 
reduction of the number of animals used (89). In 2010, the European Union (EU) adopted 
the Directive 2010/63/EU, which updated and replaced the 1986 Directive 86/609/EEC on 
the protection of animals used for scientific purposes following the 3R guidelines (90). 
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1.6.1. Regulatory aspects 
The “Note for guidance on non-clinical local tolerance testing of medicinal products” of 
European Medicine Agency (EMA) referring photosafety testing, was adopted in 1990 and 
updated in 2001 (91, 92). In 1995, the OECD supported the first initiative which referred to 
the importance of defining a regulatory environment for photosafety testing, proposing a 
new guideline denominated: “Acute dermal photoirritation screening test” (TGP951). In 
this guideline, for the first time, are included general principles for rabbit or guinea pig use 
(92, 93). In 2002, the EMA released the “Note for guidance on photosafety testing” (45, 92, 
93), where the photoallergy, photogenotoxicity and photocarcinogenicity were addressed, 
in addition to phototoxicity (45), defining photosafety tests as the adverse effects detection 
of medicinal product in the presence of UV/vis. Moreover, phototoxicity (photoirritation), 
photoallergy, photogenotoxicity and photocarcinogenesis are considered the 4 photosafety 
tests and conditions are advised, as well as, information about testing procedures for each 
type of photosensitivity, experimental procedure for photosafety in general, sources/light 
irradiation conditions and metabolic activation. In general, the performance of methods 
validated in vitro in all photoreactive compound bioavailable to the skin or eye is 
recommended (45, 92, 93).  
In United States of America (USA), once the FDA published in 2003 the “Guidance for 
industry on photosafety testing”, regulations for performing photosafety tests in medicines 
manufacture were developed (92, 93). The FDA guidance is very similar to European 
guidance mentioned above on photosafety testing. However the FDA guidance does not 
recommend non-clinical test models to test photoallergy (4) and does not recommend 
specific tests (92). The in vitro assay 3T3 Neutral Red Uptake Phototoxicity Test (3T3 
NRU-PT) is also recommended for phototoxicity test, but it is not recommended for 
products insoluble in water or for evaluation of complete formulations (4). Therefore, 
in contrast with the EMA guideline, the use of animal testing is encouraged (4, 92, 93), 
because in vitro assays are considered not predictive of the in vivo situation (4), and 
clinical studies are reported using photoreactive compounds in the skin or eyes at levels 
sufficient to cause photoirritation (92). 
The OECD test guideline 432 (2004) has the main objective to define the in vitro 3T3 
NRU phototoxicity test conditions, giving orientations of cell preparation, media and 
culture conditions, preparation of tests substances, irradiation conditions and final test 
conditions of 3T3 NRU-PT (92). 
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The adoption in 2008 of the “Concept paper on the need for revision of the note for 
guidance on photosafety testing” of EMA was the first specific step towards consensus of 
photosafety tests regulation, resulting in the International Conference on Harmonization 
(ICH) consensus (92, 93), denominated guideline ICH topic M3 (R2) of 2009: “Guideline 
on non-clinical safety studies for the conduct of human clinical trials and marketing 
authorization for pharmaceuticals” presenting several phototoxicity tests conditions (92). 
Finally, the ICH S10 of 2012, “Guidance on photosafety evaluation of pharmaceuticals” 
contained in more detail the strategies for photosafety evaluation (46).  
 
Table 3. Summary of the photosafety testing regulation. 
Name Year Type 
Institution 
responsible 
Region 
Type of 
photosensitivity 
“Acute dermal photoirritation screening test” 
(TGP951) 
1995 Guidance  OECD Europe Phototoxicity 
“Guidelines for the Safety Assessment of a 
Cosmetic Product” 
1997 Guideline Colipa Europe 
Phototoxicity 
Photomutagenicity. 
“Note for guidance on non-clinical local 
tolerance testing of medicinal products” (final 
version) 
2001 Guidance  EMA Europe Phototoxicity 
"Note for guidance on photosafety testing" 2002 Guidance  EMA Europe 
Phototoxicity 
Photoallergy  
Photogenotoxicity  
Photocarcinogenicity  
“Guidance for industry on photosafety 
testing” 
2003 Guidance FDA USA 
Phototoxicity 
Photoallergy  
Photogenotoxicity  
Photocarcinogenicity 
“In Vitro 3T3 NRU phototoxicity test” 2004 Guidance  OECD Worldwide Phototoxicity  
 “Guideline on non-clinical safety studies for 
the conduct of human clinical trials and 
marketing authorization for pharmaceuticals” 
topic M3(R2) 
2009 Guideline ICH Worldwide 
Phototoxicity 
Photocarcinogenicity 
General photosafety 
 “Non-clinical evaluation for anticancer 
pharmaceuticals” topic S9 
2009 Guideline ICH Worldwide Phototoxicity 
Cosmetics Regulation (EC) No 1223/2009, 
Annexe I 
2009 Regulation 
European 
Commission 
Europe Phototoxicity 
“Guidance on the safety assessment of 
nanomaterials in cosmetics” 
2010 Guidance  SCCS Europe 
Phototoxicity 
Photogenotoxicity 
Photoclastogenicity 
“Guidance on photosafety evaluation of 
pharmaceuticals” S10 
2012 Guidance  ICH Worldwide 
Phototoxicity 
Photoallergy 
 Photogenotoxicity 
 Photocarcinogenicity 
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Cosmetics 
For cosmetics and personal care products industry, the identification of phototoxic 
potential of each individual chemicals present in final formulations is a priority (49), being 
essential to test phototoxicity of compounds for sales authorization (94), testing and 
identifying chemicals risk (49). 
According to the Cosmetics Regulation (EC) No 1223/2009, Annexe I " A particular focus 
on local toxicity evaluation (skin and eye irritation), skin sensitization, and in the case of 
UV absorption photo-induced toxicity shall be made” (95) and to evaluate the potential 
phototoxic of a substance the European Commission Scientific Committee on Consumer 
Safety (SCCS) in “Guidance on the safety assessment of nanomaterials in cosmetics” it is 
referred that there are several important points to consider, for example the applied 
method, the finished product concentration, the amount of product used in each 
application, the frequency at which the product should be used, the consumers target 
groups and their characteristics, the quantity that enter the body (absorbed fraction) and 
the exposure routes (96). 
In Europe, in 2003, the sales of cosmetics that have been tested in animals was 
prohibited by directive 2003/15/EC of the European Commission (59, 97). subsequently, in 
2009, the sales of cosmetics products, the final formulation, ingredients or their 
combination that have been tested on animals anywhere in the world, became banned in 
the European Union (EU) under the 7th amendment (EU Regulation 1223/2009) to the 
Cosmetics Directive (Directive 76/768/EEC) (95). This directive had the objective of protect 
and improve life conditions of experimental animals, with alternative in vitro tests and the 
implementation of 3R principle (59). 
In 2010, the European Commission SCCS published the “Guidance on the safety 
assessment of nanomaterials in cosmetics” stating that, for nanomaterials, no specific 
alternative method has been validated. Also, in vitro tests presently available are not 
suitable for the characterization of their dose-response, which means that the quantitative 
risk assessment of cosmetic products that use nanomaterials is presently not possible (96). 
 
Drugs 
Formerly, most of systemically administered drugs were not subject to controlled trials 
to determine their phototoxic potential. Later it was observed that some drugs were 
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phototoxic in humans. Dermatologic drugs applied topically were tested for phototoxicity 
in vivo to verify if that these absorbed light in the UVA, UVB or visible spectrum (4). 
In case of lack in data on in vivo testing for phototoxicity and photoallergy, warnings 
about potential phototoxic must be added on product labels, and adverse clinical reactions 
reported (4). Nevertheless, some drugs identified as photoirritants can obtain marketing 
authorization, but the FDA recommends that in the Summaries of Product Characteristics 
(SPCs) and Patient Information Leaflet (PIL) should not only be indicated the 
communication of risks (adverse reactions observed), but also a warning to avoid 
unprotected exposure to the sun during treatment with the drug (4, 45). There are also cases 
in which even if the compound is not referred to have toxic effects on the skin, it must be 
tested for damage in eye, observing in animals or in clinical trials (94). 
 
1.7. Phototoxicity evaluation 
1.7.1. Spectral absorption 
As referred above, a potential phototoxic compound must absorb photons to initiate the 
photochemical event. Thus, before evaluating the phototoxic potential of a compound, its 
spectral absorption must be evaluated and only when the compound absorbs between 290 
and 700 nm should the phototoxic assays be performed (48, 93). Using a 
spectrophotometer, the absorption spectra of the chemicals are measured in aqueous 
medium or in a suitable organic solvent (usually methanol) if aqueous medium is not 
appropriate (48, 59, 93).  
 
1.7.2. Light source and irradiation conditions 
As sunlight simulator, a xenon arc lamp with appropriate filters to remove the UVC and 
attenuate the UVB part of the emission spectrum is usually used, in order to simulate the 
type and dose of radiation which reaches the skin in a real situation. The irradiation dose 
should be high to ensure the efficient activation of a broad spectrum of potential 
photosensitizers, but without causing any, or hardly any, deleterious effects (45). When the 
irradiation is equal to or greater than 10 J/cm2, phototoxic reactions can be seen and below 
1-2 J/cm2 of UVA false negatives may occur (98). 
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The types of light sources most commonly used in phototoxicity testing are: emission 
spectra limited to UV radiation, such as fluorescent lamps for UVA or UVB radiation, or 
mercury arc lamps; and emission spectrum of the sunlight simulator since they emit a 
reproducible UVA spectrum with high stability and are easily accessible (98).  
Phototoxic testing of compound for skin application is mainly evaluated with UVA (3). 
However, there are phototoxic compounds that are activated by visible light (99) and UVB 
(100), or enhanced by UVB (3, 101). UVA doses ranging from 5 to 20 J/cm2 have been 
successfully used in current in vitro and in vivo phototoxicity assays (57, 98). 
 
1.7.3. Phototoxicity testing 
After the determination of the UV/vis absorption spectrum of the compound, the drug 
photochemical properties and the photochemical reactions that the active molecule may 
suffer are evaluated (4, 47). As mentioned above, in vitro tests to replace in vivo tests are 
highly encouraged (45) and in vitro methods such as the 3T3 neutral red uptake (NRU) 
phototoxicity tests are increasingly used instead of animal models, due to ethical aspects 
(94). However, many substances that have shown phototoxic activity in vitro may not show 
an effect in vivo, and vice versa. This phenomenon is caused by the physicochemical 
properties of the substance and also by the nature of the living organism. From this point of 
view some authors argue that test on vertebrate animals should not be replaced (47).  
The phototoxicity testing in animals, sometimes followed by phototoxic studies in 
humans, should be considered for all drugs and formulation components that absorb UVB, 
UVA or visible radiation and which are applied directly on the skin or eyes, which may affect 
these areas when administered systemically or are known to affect its stability (4). The ICH 
S10 divides the photosafety evaluation in to three steps: UV spectral analysis for evaluating 
UV-absorbing properties, ROS assay for photoreactivity and 3T3 NRU PT (59). 
Notably, a compound that does not reveal phototoxic effects may reveal other adverse 
effects when exposed to sunlight. Thus, other tests such as photoalergic, photogenotoxic 
and photocarcinogenic tests should be performed to confirm the photosensitizers effect of 
the compound (Figure 8) (41). 
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1.7.4. In vitro assays 
Several in vitro assays to determine the phototoxicity of chemical compounds are 
frequently described in the literature. A summary table (table 4) with the comparison of 
four different in vitro assays is shown below, presenting their advantages and 
disadvantages, the cellular model used and what it is possible to determine with each assay. 
 
Table 4. Comparison of four commonly used in vitro phototoxicity test.  
 
Test Advantages Disadvantages Model Determinations 
3T3 NRU PT 
- The only test that predicts 
correctly the phototoxic potential 
of test chemicals in humans 
- First tested in vitro according to 
the OECD 432 guideline 
- Does not foresee 
other adverse effects 
- Does not foresee 
effects of 
metabolites or 
mixtures 
-  mice BALB/c 3T3 
fibroblasts 
- Human 
keratinocyte cell line 
(HaCaT) 
Phototoxicity 
 
RHE-PT 
- Pure chemicals or complex 
mixtures can be applied as in a in 
vivo situation 
-  Concentrations applied are 
closer to real exposure conditions 
-  Exposure time and spectrum of 
simulated sunlight similar to the in 
vivo situation 
- Simulating adsorption and 
penetration of the skin 
- The number of 
commercial 
suppliers is limited 
-  Lack of skin 
appendices that can 
influence the 
sensitivity of the 
skin 
- Very expensive  
- Skin fibroblasts  
(dermal models) 
-  Skin keratinocytes 
and a stratum 
corneum  (epidermal 
models)  
- Fibroblasts, 
keratinocytes and a 
stratum corneum ( 
full skin models) 
Phototoxicity 
RBC-PT 
- Includes photochemically 
induced met-Hb formation  
- Mammalian erythrocytes  are 
readily available 
- Erythrocytes can be exposed to 
more-intensive UV irradiation  
- Erythrocytes do not contain a 
nucleus  
- Cells can be exposed to the entire 
solar spectrum for prolonged 
periods 
- Low specificity and 
low negative 
prediction 
- Not a stand-alone 
test 
- Mammalian 
erythrocytes   
Phototoxicity 
(Photohaemolysis) 
Yeast assay 
- Ability to withstand quite long 
exposures to UVB, UVA, solar 
simulated or solar radiation  
- Useful for testing reciprocity 
between light exposure and drug 
concentration and dose-rate 
effects 
- Lack of data in the 
literature 
- Inadaptability to 
some antibiotics 
-Facultative 
anaerobic yeast  
such as  S. cerevisiae 
- Phototoxicity 
- Photomutagenic 
- Genotoxicity 
- Photogenotoxicity 
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The in vitro 3T3 NRU-PT is an alternative to in vivo tests, being the first in vitro test 
included in the OECD guideline 432 (94). In addition, it was also officially accepted by the 
EU Commission and by the EU member states in the  Directive 2010/63/EU (102). For this 
reason, the use of this assay is recommended, as described in more detail bellow. 
 
3T3 Neutral Red Uptake Phototoxicity Test (3T3 NRU-PT) 
The phototoxicity assay 3T3 NRU consists in comparing the cytotoxicity of a chemical 
compound in the presence and absence of a non-cytotoxic dose of UV/vis in order to identify 
its phototoxic potential induced by chemical excitation after radiation exposure (45, 48). In 
this assay, cytotoxicity is assessed by the reduction of vital dye (neutral red) absorption and 
consequent reduction of its concentration, 24 hours after treatment with test compound 
and irradiation (103) (Figure 9). The neutral red (NR) is a weak cationic dye that readily 
penetrates cell membranes of living cells by active transport, being accumulated in 
lysosomes (48, 104). Thus, it is possible to distinguish between viable, damaged, or dead 
cells (48, 104). 
To validate the assay, 11 laboratories have tested 30 blind-coded chemicals, and based 
on the validation protocol used, a highly detailed OECD test guideline which includes the 
use and procedures of the test (OECD 432) was adopted (49). 
Since some excipients may affect the photosensitive properties of the active substance, 
the test should be conducted with the final product formulation. However, due to solubility 
problems, that may not be possible in cell culture. As a solution to this problem, and since 
in vitro tests, such as tree-dimensional skin models (3-D) are not yet validated, the in vivo 
studies can be performed in this situation (45). 
 
Advantages and disadvantages 
The comparison between 3T3 NRU and in vivo photopatch tests showed that the first is 
able to predict correctly the phototoxic potential of chemicals (41). Thus, substances 
identified as phototoxic with this assay are considered as such in vivo (animal and human), 
after systemic application and distribution to the skin, or after topical application (45).  
The disadvantages reported in literature for this assay consist, mainly, in the fact that it 
does not provide information about other adverse effects, such as photogenotoxicity, 
Bruna Maciel 
22 
 
photoallergy or photocarcinogenicity. However, there are other weak points described, such 
as being able to not determine the phototoxic potency or the effect of metabolites or 
mixtures (48). Moreover, for some insoluble substances or complete drug formulations, this 
assay is not adequate (4). 
 
Figure 9. Schematic representation of the experimental test procedure  of the 3T3 NRU phototoxicity 
(105). 
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OECD Test Guideline 432 provides the following parameters for predicting 
phototoxicity: the photo irritation factor (PIF) and mean photo effect (MPE) (49, 58): 
• Photo irritation factor (PIF) – compares the half maximal inhibitory concentration 
(IC50) values, i.e., 50% reduction in the uptake of NR for the cells exposed to UVA radiation 
compared with the unexposed (49). To calculate this, the ratio between the IC50 without 
UVA and the IC50 with UVA is used (106), as the following calculation: 
PIF =
IC50 (-Irr) 
IC50 (+Irr)
  (48) 
• Mean photo effect (MPE) – statistical comparison of the dose response curve of cells 
exposed and not exposed to UVA radiation (49, 106), i.e., a comparison of the area under 
the curve (AUC) of the concentration response curves obtained from cells exposed and not 
exposed to UVA radiation (107) (Table 3).  
The compounds are considered not phototoxic, probably phototoxic or phototoxic 
according to the criteria defined on table 5. 
 
Table 5. Evaluation of phototoxicity depending of the PIF and MPE (106). 
PIF MPE 
1) No Phototoxicity <2 <0.1 
2) Probable Phototoxicity 2 – 5 0.1 - 0.15 
3) Phototoxicity >5 >0.15 
 
The use of the BALB/c mice fibroblast cell line 3T3 is recommended in the standard 
protocol of the EU and OECD guideline. However, other cell lines can be used with the same 
test protocol, if the culture conditions are adapted to the specific cell needs (45) producing 
equivalent results (48). The protocol was successfully used with human keratinocytes in a 
blind study conducted with chemicals in EU/COLIPA validation study (108). Since 
keratinocytes represent the major cell type in the epidermis and this layer is the most 
relevant to induce epidermal irritation in humans, the human keratinocyte cell line (HaCaT) 
can also be used. Furthermore, this cell line provides a source of cells practically 
inexhaustible, allowing  large laboratory reproducibility (106). 
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ROS generation (DCFH-DA) assay 
As referred above, ROS generation is one of the phototoxic reaction consequences. The 
toxicity is due to the formation of oxidizing agents, such as O2 •, H2O2, HOCl, NO, NO2, 
NH2Cl. To detect the production of reactive oxygen species in the cells, 2',7'- 
dichlorodihydrofluorescein diacetate (DCFH-DA) is frequently used. This assay is based in 
fluorescent compound production when ROS are present in the medium (109). DCFH-DA, 
a nonfluorescent molecule can permeate cell membranes and accumulate in the cytoplasm, 
where esterases remove the acetate to produce 2',7'-dichlorodihydrofluorescein (DCFH) a 
polar compound that does not permeate cells (109, 110). Finally, DCFH is quickly oxidized 
to 2',7'-dichlorofluorescein (DCF), the measured fluorescent compound (excitation at 485 
nm and emission at 530 nm) (109) (Figure 10).  
 
 
Figure 10. Scheme deficting the conversion of DCFH-DA into DCF (119). 
 
Advantages and disadvantages  
The DCFH-DA assay has the advantage of being sensitive to many ROS, while other 
probes can only be oxidized by one ROS (usually H2O2) and is also less expensive than other 
fluorescent probes. However, DCFH-DA is less sensitive and not as cost effective compared 
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to others. Besides this, the DCFH-DA is insoluble in water (109) and sensitive to UV 
radiation. A decrease in response in ROS generation when compared with the absence of 
UV was observed (111). 
 
Reduced (GSH) and oxidised glutathione (GSSG) by DTNB-GSSG reductase 
recycling assay 
As referred above, the reduced (GSH) and oxidised glutathione (GSSG) are part of the 
cellular antioxidant system, so their determination is important to study the ROS 
generation caused by irradiation of a compound. In the presence of GSH the compound can 
form (glutathion-S-yl)-adducts and the GSH conjugates remain redox active and can be 
oxidized, leading to the reductive addition of a second molecule of GSH to yield 2,5-bis-
(glutathion- S-yl)- conjugates (112). 
The assay for calculating the total GSH (GSH + GSSG, in GSH equivalents) is a specific 
and sensitive enzymatic procedure. GSH is oxidized by 5,5’-dithiobis(2-nitrobenzoic acid) 
(DTNB) (113) producing GSSG with stoichiometric formation of 5-thio-2-nitrobenzoic acid 
(TNB). Afterwards, GSSG is reduced to GSH through the highly specific glutathione 
reductase (GSSG reductase) and NADPH. Finally, the TNB (5-thio-2-nitrobenzoic acid) 
formation rate is evaluated at 412 nm (or 405 nm) and corresponds to the GSH and GSSG. 
The assay may be monitored at 340 nm by following NADPH consumption in the reaction 
(114). 
 
1.7.5. In vivo assays 
In vivo assays are also used to determine the potential phototoxicity of a chemical. 
However, as referred above, due to ethical restriction they are utilized with less frequency. 
A summary of these assays is provided (Table 6), including the advantages and 
disadvantages, the animal models used and the determinations that are possible to achieve 
with each assay. 
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Table 6. A comparison of different in vivo phototoxicity test. 
 
 
1.8. Analyzed compounds 
Despite the existence of set of antioxidant defenses that protect the skin against UV-
induced oxidative stress, chronic and excessive exposure to UV-radiation can lead to 
oxidative stress and oxidative damage (23). As a solution to this, the topical application of 
antioxidants has been used (115-117), owing to their ability to prevent or minimize the UV 
induced-deleterious effects of reactive species on the skin (117). 
In this work several compounds were analyzed: 1,2-Dihydroxyxanthone (1,2- DHX), 5-
methoxypsoralen (5-MOP), Chlorogenic acid (CA) and chlorogenic acid persulfate (CAP), 
Castanea sativa leaf extract, Hydrogen peroxide (H2O2), resveratrol (RSV) and its 
derivatives, Avobenzone, Ethylhexyl Methoxycinnamate (EHMC), Acetylsalicylic acid 
(ASA), Chlorpromazine (CPZ), Diclofenac, Hexachlorophene, Quinine HCl and Sodium 
Lauryl Sulphate (SLS). 
Test Advantages Disadvantages Models  Determinations 
Animal 
- Similarity with 
human condition, 
such as 
homeostatic 
mechanism. 
- Ethical issues; 
- 3R restrictions; 
- Without formal 
validation. 
- BALB/c mice; 
- Guinea pig; 
- OFA-Hr/hr 
hairless rats; 
- Rabbit; 
- Swine; 
- Squirrel monkey; 
- Hamster. 
- Phototoxicity; 
- Photoallergy; 
- Photogenotoxicity; 
- 
Photocarcinogenicity. 
Photopatch 
- Predict human 
condition; 
- Distinguish 
photoallergic from 
phototoxic 
response. 
- Difficulty in 
standardizing 
procedure; 
- Inter-individual 
variation; 
-Ethical issues. 
- Human. 
- Phototoxicity; 
- Photoallergy; 
- Photogenotoxicity; 
- 
Photocarcinogenicity. 
Invertebrate 
animals 
 
- Ideal initial 
biological 
screening method; 
- Rapid; 
- Simple; 
- Cheap. 
- Without formal 
validation; 
- Protocol is not 
well defined; 
- Does not predict 
the phototoxicity 
by itself 
- Crustaceans of 
genera Artemia 
and Daphnia. 
- Phototoxicity 
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1.8.1. Positive controls 
5-methoxypsoralen (5-MOP) 
5-Methoxypsoralen (5-MOP, Bergapten) is a natural furocoumarin from several plant 
species (118-121) with antioxidant activity observed in vitro (119). The exposure to this 
compound can occur by food and drink ingestion and using perfumes and cosmetics with 5-
MOP in their composition (120, 121). 5-MOP has been mainly used in photochemio therapy, 
such as psoriasis and vitiligo therapy due to its interaction with UV radiation, increasing the 
cutaneous photosensitivity (118, 119, 121, 122). For this reason, this compound is usually 
recommended as positive control in phototoxicity assays (48). It also shows anti-
inflammatory, antidepressant, anticonvulsion and anticancer effects (119, 121). Since this 
compound has potential phototoxic properties (59, 123) 5-MOP was used as a positive 
control in this work. 
 
Figure 11. Chemical structure of 5-MOP. 
 
Chlorpromazine (CPZ) 
Chlorpromazine is as lipophilic drug (124) used in antipsychotic treatments (125-127), 
such as schizophrenia, the manic phase of bipolar disorders and other psychotic disorders. 
Studies revealed also antibacterial, anticancer, antiprionic, antiviral and multidrug 
resistance reversal activity (126). However, this drug can cause hepatotoxicity (125, 126), 
extrapyramidal effects, hyperprolactinemia, agranulocytosis, skin (e.g., jaundice and 
pigmentation, lichenoid, photosensitivity, pigmentation, subacute lupus erythematosus, 
toxic epidermal necrolysis, urticaria) and ocular (e.g., retinopathy, cataract) disorders. CPZ 
leads to oxidative stress (125, 126) which can cause tardive dyskinesia, cholestasis, cataract 
and retinopathy age-related macular degeneration. CPZ interferes with endogenous 
melanin causing hyperpigmentation and phototosensitivity, characterized by brown 
discoloration in skin sun-exposed areas and may even lead to a darker grayblue color (126). 
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Due to the photosensitivity of this compound it is frequently recommended as a positive 
control in phototoxicity assays (48). 
 
Figure 12. Chemical structure of CPZ. 
 
Hydrogen peroxide (H2O2) 
The use of commercial H2O2 is mainly in rocket propulsion. However, is also used as a 
conditioner, maturing and bleaching agent in food, as a strong oxidizer, anti-infective, clear 
and colorless liquid (128). The oxidative stress in cells leads to hydrogen peroxide 
formation, which glutathione peroxidase or catalase convert H2O2 in water and oxygen 
(129). Previous studies have shown that ROS can induce inflammatory conditions when the 
skin is exposed to UV radiation (13). In this work, hydrogen peroxide was used as positive 
control in ROS generation studies, so the cytotoxic and phototoxic evaluation must be 
performed to outwit its influence in ROS generation assay. 
 
Figure 13. Chemical struture of H2O2. 
 
Quinine HCl 
Quinine is an alkaloid found in tree bark of genus Cinchona (130). This compound and 
its derivatives are frequently used in protozoal infection treatment like malaria (128, 130, 
131) and nocturnal leg cramps. Due to the bitter taste of quinine, it is also used as bittering 
agent in tonic type drinks (131, 132). In street drugs, quinine is found as an adulterant of 
heroin, cocaine and other (133). Quinine causes photoallergic and photoxic effects, the latter 
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probably via singlet oxygen production and interaction with intracellular targets (132). 
Quinine derivatives appear to be a photosensitizer for biological systems. Fluorescence 
events were also observed for quinine (130). Because quinine is a phototoxic compound, it 
is suggested as a positive control for phototoxicity assays (48). 
 
Figure 14. Chemical structure of Quinine HCl. 
 
1.8.2. Negative controls 
Acetyl salicylic acid (ASA) 
Acetylsalicylic acid (ASA), most commonly known as Aspirin is a drug used for treatment 
of pain, fever, inflammation (134), heart attacks, thromboses (135, 136), strokes and 
ischemia prevention (137) and anticoagulant activity as a long-term treatment (135, 136). 
Recent studies showed that ASA might reduce the risk of cancer and reduction in metastasis 
(138). This compound is frequently recommended as a negative control in phototoxicity 
assays (139, 140). 
 
Figure 15. . Chemical structure of ASA. 
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Hexachlorophene  
Hexachlorophene is an organochlorine compound, mainly used as an antiseptic in 
topical applications until the 1970s. Some studies have demonstrated that hexachlorophene 
can cause neurotoxicity in animal models (141). Because of its potential neurotoxicity in 
humans, its use has been regulated. Hexachlorophene is used in germicidal soaps as anti-
infective, topical and detergent (128). The OCDE recommended this compound as a 
negative control in phototoxicity assays (48). 
 
Figure 16. Chemical structure of hexachlorophene. 
 
Sodium lauryl sulphate (SLS) 
Sodium lauryl sulphate is an anionic surfactant especially used in several cosmetic 
products (142, 143). It is formed from lauryl alcohol, followed by neutralization with sodium 
carbonate and used in detergent, textile industry and toothpastes formulation (128). SLS is 
a not phototoxic compound used as a negative control in phototoxicity assays (48, 144). 
 
Figure 17. Chemical formula of SLS. 
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1.8.1. Raw compounds 
1,2-Dihidroxyxanthone (1,2- DHX) 
Chemically, xanthones are a class of oxygenated heterocyclic compounds with a dibenzo-
γ-pyrone scaffold (145). Many xanthones with phenolic groups have been described for their 
antioxidant properties (115, 146, 147), being considered as one of the most important 
natural antioxidants (115, 147). These properties conduct to their anti-inflammatory, cancer 
chemopreventive (115, 147, 148), antibacterial and cardioprotective activities (115, 147). 
Xanthone and its derivatives have also been demonstrated to have antidepressant activity 
(149). In the present work, the phototoxicity of 1,2-DHX was assessed. 
 
Figure 18. Chemical structure of 1,2-DHX. 
 
 Avobenzone 
Avobenzone is a UV-filter and its use has been increasing over the last years due to its 
strong UVA attenuation, becoming probably the most important UVA filter. However the 
degradation of this active ingredient under UV exposition is significant (35, 79, 80) which 
may lead to photoproduct generation (35). For this reason, its use is usually combined with 
photostabilizers, including others UV-filters, in order to increase the efficacy of sunscreens. 
Avobenzone has been shown to have potential phototoxicity in 3T3 NRU with 3T3 BALB/c 
fibroblast (35, 80, 81), but some studies employing in human skin models considered it not 
phototoxic (80, 140). Considering the photo-instability and positive results in 3T3 NRU, its 
phototoxic potential in human keratinocytes is an interesting subject of study.  
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Figure 19. Chemical structure of Avobenzone. 
 
Chlorogenic acid and chlorogenic acid persulfate 
Chlorogenic acid (CA) is a polyphenolic component present in several plants and is very 
common in coffee. This compound has shown anti-inflammatory, cardioprotective, anti-
tumor, lipid peroxidation inhibitory (150, 151), antioxidant (150-152), antibacterial, 
hypoglycemic, hypolipidemic and anti-hypertensive activities (151). 
Chlorogenic acid persulfate (CAP) is obtained from chemical synthesis and has shown in 
vitro anticoagulant, antiplatelet and antioxidant activities (153, 154). 
Due to antioxidant proprieties and because they are used as possible ingredients of 
cosmetic formulations, the phototoxic potential study of both compounds is an important 
factor. 
         
Figure 20. A) Chemical structure of CA B) Chemical structure of CAP.  
 
Castanea sativa leaf extract 
Castanea sativa (C. sativa) belongs to the Fagaceae family (155, 156), a flowering plant 
cultivated mainly in temperate regions such as Southern Europe, Asia and North of Africa 
Bruna Maciel 
33 
 
(156). C. sativa is a known source of phenolic active compounds (155, 157) and has several 
medicinal properties including antioxidant, chemopreventive, anti-inflammatory, 
neuroprotective, antiatherogenic, anti-thrombotic, antiangiogenic, cerebrovascular and 
peripheral vascular protective effects, being used in the treatment of various respiratory 
diseases (asthma, cold, cough, expectorating, bronchitis and bronchial affections), 
cardioprotective effects (155), diarrhea and rheumatic conditions, lower back pain, and stiff 
joints or muscles (156). 
C. sativa extracts have the ability of scavenging different ROS, such as superoxide radical 
(O2•-), hydroxyl radical (HO•), peroxyl radical (ROO•), hydrogen peroxide (H2O2) and 
singlet oxygen (1O2), which can lead to skin aging (157). The use of hydroalcoholic extracts 
from C. sativa leaves (which contain rutin, ellagic acid, hyperoside, isoquercitrin and 
chlorogenic acid) in cosmetic formulations has been considered safe and suitable for 
preventing and treating photoaging (158). C. sativa has in its composition chlorogenic acid 
at 2.23 mg/g of extract (22), so it is important to correlate its phototoxic potential with the 
amount in C.sativa extract. Besides that, since this extract releases ROS and its use has been 
increasing in cosmetic formulation against photoaging, its phototoxic potential is a 
determining factor in cosmetic safety. 
 
Diclofenac 
Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) (159, 160), used against 
pain, fever, and inflammation. This compound produces ROS leading to hepatotoxicity 
(159) and has potential photosensitizing in photohemolysis test (160, 161). Some studies 
have shown that its photosensitization is due to its photoproducts and not due to the parent 
drug (160). For these reasons, the study of the phototoxic potential in human keratinocytes 
was considered important. 
 
Figure 21. Chemical structure of Diclofenac. 
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Ethylhexyl methoxycinnamate (EHMC) 
Ethylhexyl methoxycinnamate (EHMC) or octylmethoxycinnamate (OMC) (162) is an 
UVB filter (80, 163) with low cost, high compatibility with cosmetic formulations (164) and 
wide range of wavelengths (165), making it one of the most frequently used UV filters in the 
world (162-166), present in 90% of sun lotions (167) in 1:10 parts per weight (162). Due to 
its lipophilicity (80, 168), EHMC can bioaccumulate in fish, invertebrates and human breast 
milk (168), so the study of its toxicity is important, specially the phototoxicity study as it is 
constantly exposed to sun light. Several studies show that EHMC undergoes UV-mediated 
photodegradation and photoisomerization, making this compound photo-unstable (164, 
165, 169, 170) by itself or in combination with other UV-filters (170). However, various 
studies have shown that EHMC in 3T3 Balb/c fibroblast was not phototoxic (35, 79, 81, 171). 
Therefore, the EHMC phototoxic potential is a point of interest. 
 
Figure 22. Chemical structure of EHMC. 
 
Resveratrol and its derivatives 
Resveratrol (RSV, 3, 5, 4’ -trihydroidroxystilbene) a natural antioxidant compound is a 
non flavonoid polyphenol (172, 173), present in different plants (peanuts, pistachio nuts, 
red grape seeds and skins, red wine, and other plant-derived food products) (173). This 
compound is present in Z- and E-isomeric forms (172). Several studies have shown the 
beneficial health effects of RSV and its use has been proposed in the treatment or prevention 
of different diseases (174), such as chemopreventive agent for skin cancer (172). Topical 
application of E-resveratrol (E-RSV) is known to prevent in vivo UV-induced skin damage 
and skin cancer (172, 174), treating in vitro melanoma inducing cellular apoptosis. 
However, E-RSV isomerizes under UV exposure, converting mostly in the less active Z- 
isomeric form (172). 
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The resveratrol glycoside sulfate (RGS, 3, 5, 4’ -trihydroidroxystilbene-3-β-D-
glucopyranoside persulfate) was obtained by chemical synthesis and demonstrated an in 
vitro anticoagulant and antiplatelet activities (153, 154).  
Due to UV isomerization of RSV, it is relevant to study the potential phototoxic of RSV 
and of its derivatives. 
           
Figure 23. A) Chemical structure of RSV B) Chemical structure of RGS  
 
 
Table 7. Summary of used compounds and their molecular weight. 
 NA- not applicable 
 
Compounds 
Molecular weight 
(g/mol) 
Compounds 
Molecular weight 
(g/mol) 
1,2- DHX 228 DIC 296.15 
5-MOP 216.19 EHMC 290.4 
ASA 180.16 H2O2 34.01 
Avobenzone 310.39 Hexachlorophene  406.90 
CA 354.31 Quinine HCl 396.91 
CAP 864.53 RGS 1002.65 
C. sativa leaf extract NA RSV 228.23 
CPZ 318.86 SLS 288.372 
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2. Aim 
The aim of this project was to implement a phototoxicity assay in a human keratinocyte 
cell line (HaCaT) based on the 3T3 Neutral Red Uptake Phototoxicity assay (3T3 NRU-PT) 
reported in OCDE432 guideline, using a UVA/UVB Osram lamp, and to evaluate the 
phototoxic potential of a series of raw materials for cosmetic and pharmaceutical products 
with the developed methodology. An additional aim was to perform preliminary tests 
regarding the implementation of a phototoxicity test using oxidative stress measures (tGSH 
and ROS generation) as endpoints. 
 
3. Materials and methods 
3.1. Materials 
3.1.1. Raw materials 
Resveratrol (RSV) was purchased from Fragon (Brazil). Ethanol (EtOH) was supplied by 
Aga (Portugal). Glycerin, acetyl salicylic acid (ASA) and sodium lauryl sulphate (SLS) were 
purchased from Acofarma (Spain). Acetic acid glacial and hydrogen peroxide (H2O2) 30% 
w/v were purchased from Panreac química SA (Spain). Avobenzone (butyl 
methoxydibenzoylmethane, eusolex 9020) and EHMC (octylmethoxycinnamate, ethylhexyl 
methoxycinnamate, eusolex 2292) were purchased from Merck (Germany). 
Hexachlorophene was purchased from Vaz Pereira (Portugal) and chlorogenic acid 
hemihydrate (CA) from Fluka (Switzerland). 1,2-Dihidroxyxanthone (1,2-DHX), 
chlorogenic acid persulfate (CAP), resveratrol glycoside sulfate (RGS) and Castanea sativa 
extract (C. sativa) were synthetized by the Laboratory of Organic and Pharmaceutical 
Chemistry (LQOF) of the Faculty of Pharmacy, University of Porto. Immortalized human 
keratinocyte (HaCaT) cell line was obtained from Cell Lines Service (CLS) (Germany). 
Dulbecco’s Modified Eagles’s Medium (DMEM) with 4,5 g/L D-glucose and pyruvate, 
DMEM with 4,5 g/L D-glucose, L-glutamine, 25mM HEPES and no phenol red, inactivated 
fetal bovine serum (FBS), penicillin-streptomycin solution, Dulbecco’s Phosphate Buffered 
Saline (DPBS) without calcium chloride and magnesium chloride and 0,25% trypsin-
ethylenediaminetetraacetic Acid (EDTA) solution were supplied by Gibco® Life 
Technologies (USA). Dimethyl sulfoxide (DMSO), trypan blue 0,4% solution, neutral red 
(NR) solution, quinine hydrochloride, chlorpromazine hydrochloride (CPZ), 5-
methoxypsoralen (5-MOP), diclofenac and 2′,7′-dichlorofluorescin diacetate (DCFH-DA) 
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were purchased from Sigma-Aldrich® (USA). The water used in all experiments was purified 
water obtained using a Direct-Q® Water Purification System (Merck Millipore, Darmstadt, 
Germany) with a reverse osmosis process. 
 
3.1.2. Laboratory materials 
The UVA/UVB lamp was an ultra vitalux 240V E27 from OSRAM (Germany), the heating 
ultrasonic baths used was a Bandelin Sonorex PK 100H and 96 well tissue culture plates flat 
were purchased from orange scientific (Belgium). The laminar flow chamber (HeraSafe, 
class II, model HS 12), the CO2 incubator (HERAcell 150 Air-Jacketed) and the Centrifuge 
Series (Multifuge™ X1) were from Heraeus (Germany). The waterbath was from memmert 
and the Counting chambers, Neubauer improved bright-line (0,0025mm2) were purchased 
from Hirschmann (Germany). The inverted microscopes used was an AE2000 from Motic 
(Germany). The Microplate Reader (Synergy HT) and the Gen5 software used to read the 
microplates and transform the data in images were purchased from BioTek (United States). 
The spectrophotometer used was the Spectrophotometer Jasco UG50. 
 
3.2. Methods 
3.2.1. Cell culture 
The in vitro experiments were conducted with the HaCaT cell line. These cells were 
originally obtained from Caucasian male aged 62 skin and are an immortal non-cancerous 
human keratinocyte cell line of adherent cells that form in monolayers. 
Cells were maintained during all the assays at 37°C in a humidified atmosphere of 95% 
air and 5% CO2 in the incubator in DMEM with 10% FBS and 1% antibiotics. Using an 
inverted microscope, cell confluence was observed and if the cells reached 70-80% 
confluence, subculture was done to prevent cell death. For this purpose, the culture medium 
was aspirated and the cells were washed with DPBS, 1o mL of trypsin-EDTA was added and 
incubated for 5 to 8 minutes at 37°C in a 5% CO2 atmosphere. After cell detaching, medium 
was added in order to block the trypsin action and cell suspension was centrifuged at 416G 
for 5 minutes. The supernatant was discarded, the pellet ressuspended in culture medium 
and cells were counted. For cell counting: 50 μL of cell suspension was added to 50 μL of 
trypan blue vital dye (1:10), ressuspended, placed in a Neubauer chamber and the viable 
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cells were counted. The number of cells in the total volume was calculated with the following 
equation: 
Number of cells/mL =  
n
4
× 104 X 
1
d−1
  Equation 1) 
where, n is the number of viable cells counted and d is the dilution coefficient. 
For cell freezing, DMSO (5% v/v) was used as a cryo-preservative to prevent the 
formation of crystals during the storage phase. 
 
HaCaT cell line  
In order to characterize the cell line generation time, i.e., how long it is necessary for a 
population of cells to duplicate, five 25 cm2 flasks with 1×105 cells were seeded and 
incubated for 24 hours at 37°C in a 5% CO2 atmosphere to a complete adherence. Then, the 
cells of each flaks were counted at different times using 50 μL of cell suspension added to 
50 μL of 0.4% trypan blue vital dye (1:1) and the number total of cells in each flak was 
calculated using equation 1. The results were plotted in a graphic with cell number versus 
time, from which the generation time was calculated using linear regression analysis. 
 
3.2.2. Implementation and optimization of phototoxicity in vitro test 
Irradiation optimization 
Irradiation dose and temperature control 
Using a radiometer, the height of the UVA/UVB Osram lamp was adjusted in order to 
irradiate the cells with an irradiation dose of 1.7mW/cm2. 
Regarding temperature control over the irradiation time, DMEM without phenol red, at 
37ºC, was added to a 96-well plate and irradiated inside a Styrofoam recipient containing a 
water-cooling system. Medium and water temperature were measured during the 
irradiation at several times: 1, 3, 5, 7, 10, 12, 15, 17, 20, 23, 25 and 30 mins. 
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HaCaT sensitivity to radiation 
The procedure, previously optimized, was used to study the cell sensitivity to radiation. 
For this purpose, 9 plates were irradiated, with an equivalent plate kept in the dark, at 9 
irradiation times: 1, 3, 4, 5, 7, 10, 15, 20 and 30 mins. Then the cell viability was calculated 
for each time using the following calculation: 
Cell viability (%) = ( 
plate (+irr)
plate (−irr)
 )  X 100  Equation 2) 
 
Optimization of neutral red uptake assay 
In order to optimize the NR uptake assay several factors were tested, such as the optimal 
cell density, the concentration and the incubation time with the NR solution. With regard 
to cell density, 2.5×103, 5×103, 1×104, 2×104 and 5×104 cells/well were seeded on 96-well 
tissue culture plates (150 µL/mL) and incubated at 37°C in a 5% CO2 atmosphere for 24 
hours. Afterwards the medium was removed, cells were washed with DPBS, and fresh 
culture medium was added and incubated under the same conditions for 24 hours. Since 
the NR could precipitate, the NR solutions were prepared every second day and incubated 
overnight at 37°C in a 5% CO2 atmosphere protected from light. Before the addition to the 
wells, the NR solution was centrifuged at 1500 x g for 10 minutes and filtered (5 μm). Finally, 
the medium of each plate was removed, cells were washed with DPBS and 33, 50, 100 and 
330 μg/mL NR solution in DMEM were added and incubated for 2, 3 or 4 hours. After this, 
NR solution was removed, the cells were washed once with DPBS previously heated at 37°C 
and a NR desorb solution (50% ethanol:1% acetic acid:49% distilled water) was added to 
extract the NR dye from the cells. For the reading procedure, each plate was placed in a 
microplate shaker for 10 minutes, at room temperature and protected from light, in order 
to extract all the NR from the cells and obtain a homogeneous solution. Finally, the 
absorbance was measured at 540 nm. 
 
Optimization of ROS generation assay using DCFH-DA 
In order to optimize the ROS generation assay several factors were tested, such as the 
optimal cell density, the concentration and the incubation time with the DCFH-DA. With 
regard to cell density, 2.5×103, 5×103, 1×104, 2×104 and 5×104 cells/well were seeded on 96-
well tissue culture plates and incubated at 37°C in a 5% CO2 atmosphere for 24 hours. 
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Afterwards, the medium was removed, cells were washed with DPBS, and complete culture 
medium with different concentrations of DCFH-DA (5, 10, 25 and 50 μM) was added and 
incubated for two different times (30 min and 1 hour) under the same conditions. 
Afterwards, the DCFH-DA solution was removed, the cells were washed with DPBS and a 
solution of different concentrations of H2O2, a positive control, and the negative control with 
only cells in DMEM without phenol red (400 and 700 μM) was added at different times: 1, 
20 and 24h. Following thus incubation, the fluorescence was measured using a fluorescence 
plate reader with a baseline of 485 nm excitation and 530nm emission. 
 
Optimization of a UV-mediated ROS generation assay using the DCFH-DA 
probe 
The procedure, previously optimized in section 3.2.2.1.1 and 3.2.2.1.3, was used to study 
the radiation influence in the DCFH-DA, since this probe has been reported to be 
photolabile (111). For this purpose, the DCFH-DA was added before and after the 
irradiation, with or without a previous washing step of cells and the increase in fluorescence 
percentage was evaluated. A positive control (H2O2) was used before and after the 
incubation with the DCFH-DA after the irradiation. Another positive control (quinine 
hydrochloride) was also tested. 
 
3.2.3. Phototoxicity study 
Test compounds conditions 
The phototoxicity and cytotoxicity of several compounds analysed, including compounds 
obtained by chemical synthesis with potential interest for topical application: 1,2-
dihydroxyxanthone (1,2-DHX), chlorogenic acid persulfate (CAP) and resveratrol glycoside 
sulphate (RGS) synthesized at the Pharmaceutical Chemistry Laboratory, FFUP. 
Resveratrol (RSV), acetyl salicylic acid (ASA), sodium lauryl sulphate (SLS), hydrogen 
peroxide (H2O2), butyl methoxydibenzoylmethane (eusolex 9020 - Avobenzone), ethylhexyl 
methoxycinnamate (eusolex 2292 - EHMC), hexachlorophene, chlorogenic acid (CA), 
quinine hydrochloride, chlorpromazine hydrochloride (CPZ), 5-methoxypsoralen (5-MOP), 
diclofenac and C. sativa leaf extract were also studied. The concentrations tested and 
solvents are described in Table 8. 
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Table 8. Summary of used compounds, their solvents and concentrations. 
Compounds Solvents 
Tested concentrations 
(Phototoxicity) 
Tested concentrations 
(Cytotoxicity and ROS) 
1,2- DHX DMSO 12.5; 25; 50; 100; 200 µM 12.5; 25; 50; 100; 200 µM * 
5-MOP DMSO 
10; 25; 50; 100; 300 µM (no irradiate 
plate) 
1; 2.5; 5; 7.5; 10 µM (irradiate plate) 
10; 25; 50; 100; 300 µM 
ASA Ethanol 96% 1388; 2775; 5551; 8326; 11101 µM 1388; 2775; 5551; 8326; 11101 µM 
Avobenzone DMSO 10; 25; 50; 100; 200 µM 10; 25; 50; 100; 200 µM 
CA DMSO 10; 25; 50; 250; 500 µM NR 
CAP DMEM 115.7; 289.2; 578.3; 867.5; 1716.5 µM NR 
C. sativa leaf 
extract 
H2O:Glicerin 
(1:1) 
5; 50; 100; 250; 500 µg/mL 5; 50; 100; 250; 500 µg/mL * 
CPZ PBS 
2.8; 28.2; 70.4; 140.9; 211.3; 281.7 µM 
(no irradiated plate) 
0.3; 2.8; 5.6; 8.5; 11.3; 14 µM 
(irradiated plate) 
10; 15; 25; 35; 50 µM 
Diclofenac DMSO 10; 25; 50; 100; 500; 1000 µM 10; 25; 50; 100; 500; 1000 µM 
EHMC Ethanol 96% 3.4; 86.2; 172.4; 344.8; 517.2; 689.7 µM 
86.2; 172.4; 344.8; 517.2; 689.7 
µM 
H2O2 DMEM 1; 100; 200; 400; 1000; 2000 µM 1; 100; 200; 400; 1000; 2000 µM 
Hexachlorophene DMSO 
61.4; 122.9; 245.8; 307.2; 491.5 µM 
(phototoxicity) 
12.3; 24.6; 61.4; 122.9; 245.8; 
307.2 µM 
Quinine HCl Ethanol 96% 
25.2; 125.9; 251.9; 503.9; 1259.7; 
2519.5 µM 
25.2; 125.9; 251.9; 503.9; 1259.7; 
2519.5 µM 
RGS Water 10; 50; 100; 500; 1000 µM NR 
RSV DMSO 100; 500; 750; 1000; 2000 µM 100; 500; 750; 1000; 2000 µM * 
SLS DMEM 
69.35; 138.7; 173.4;260.1; 346.8; 866.9; 
1733.9 µM 
69,35; 138.7; 173.4;260.1; 346.8; 
866.9; 1733.9 µM 
* Cytotoxicity previous studied at the host laboratory; NR- Not Realized. 
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To evaluate the cytotoxic and phototoxic effect of these compounds on the HaCaT cells, 
two assays were performed, the NRU and NRU-PT, after an initial optimization step. The 
ROS generation assay and total glutathione (tGSH) assay for each compound were 
performed as phototoxicity assay complement, since ROS are expected to be released when 
a phototoxic event happens. For all compounds, the cellular viability assessed through the 
lysosomal integrity was evaluated with and without irradiation and afterwards it was 
compared using the PIF index. The ROS generation was performed with the DCFH-DA 
assay. The cytotoxicity assays were conducted to assess the lysosomal integrity through the 
NRU assay. For some compounds, as referred in table 8, the cytotoxicity and the ROS 
generation were not evaluated, since it has been previously evaluated at the same laboratory 
and we ran out of ca and cap during the course of this study, respectively. 
All experiments have at least three intra-day and inter-day replicas. All results from the 
cytotoxicity and phototoxicity assays were expressed in percentage of cell viability relative 
to positive control (cells treated with the solvent) and whenever possible the concentration 
able to reduce cell viability by 50% (IC50) was calculated using linear regression analysis. 
In the ROS assay the difference between the fluorescence of treated cells and untreated cells 
was calculated and expressed as percentage. 
 
Spectral absorption 
Before performing the phototoxicity assays, the absorption spectra of all tested 
compounds were obtained. For this purpose, the tested substances were dissolved in the 
appropriate solvent at a concentration of 100 µg/mL. When this concentration was not 
appropriate a concentration of 10 µg/mL was used (e.g. EHMC, avobenzone, diclofenac, 5-
MOP, 1,2-DHX and RSV). The absorbance was evaluated in the 250-700 nm range (covering 
UV and visible light wavelengths). Blanks with each solvent were performed to eliminate 
interferences. Solvents used for each compounds were the same used at assays mentioned 
in Table 8. 
 
Study of the tested compounds phototoxic effect using the NR uptake assay 
Using the optimized condition previously described, 2×104 cells/well (optimal cell 
density) were seeded and incubated for 24 hours at 37°C in a 5% CO2 atmosphere. The 
medium was removed, cells washed once with DPBS and different test compounds solutions 
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in DMEM without phenol red were tested and incubated under the same conditions for 1h. 
After this, the plate was irradiated for 10 min at 29-32 °C, using as control an equivalent 
plate that was kept in the dark. The cells were then washed once again with DPBS and the 
medium was replaced with fresh DMEM without phenol red and incubated for 18-22h. At 
the third day, cells were washed with DPBS and complete DMEM containing 50 μg/mL NR 
(optimal concentration) previously incubate overnight, centrifuged at 1500 x g for 10 
minutes and filtered (5 μm) was added to each well and incubated for 3 hours (optimal 
incubation time) protected from light. Finally, the NR solution was removed, cells washed 
and a desorb solution added. The plate was then shaken and absorbance measured at 540 
nm as described above. The cell viability of solvent controls was evaluated using the same 
procedure. 
The results were expressed as the absorbance ratio of treated to control cells, using the 
following calculation: 
Cell viability (%) = ( 
Treated cells absorbance 
Untreated cells absorbance
 )  X 100 Equation 3) 
Then, the IC50 was determined using linear regression, to calculate the PIF. 
 
Study of the tested compounds cytotoxic effect using the NR uptake assay 
Using the procedure referred above, 2×104 cells/well were seeded and incubated for 24 
hours, the medium was removed, cells washed and different test compounds added and 
incubated for another 24 hours. At the third day, medium was removed, the cells were 
washed once with DPBS (37°C) and 50 μg/mL of NR solution previously incubated 
overnight, centrifuged at 1500 x g for 10 minutes and filtered (5 μm) was added to each well 
and incubated for 3 hours protected from light. After the incubation time, the NR solution 
was removed, cells were washed and the desorb solution added. The plates were then shaken 
as mentioned above and the absorbance measured at 540 nm. The cell viability of solvent 
controls was evaluated using the same procedure. 
The results were expressed as the absorbance ratio of treated to control cells, using 
Equation 3. 
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Study of the tested compounds ROS generation using DCFH-DA 
Using the optimized conditions, 2×104 cells/well were seeded and incubated at 37°C in a 
5% CO2 atmosphere. After 24 hours of incubation, the medium was removed, cells washed 
once with DPBS and complete DMEM containing 50μM DCFH-DA was added and 
incubated for 30min. Afterwards, the cells were washed once with DPBS and different test 
compounds were added and incubated for 24 hours. At the third day, the fluorescence was 
measured using a fluorescence plate reader with a baseline of 485 nm excitation and 530nm 
emission. A fluorescence interference of compounds without cells and a fluorescence of 
solvent controls studies were performed under the optimized procedure. 
The results were calculated as the ratio between the fluorescence of treated cells and 
untreated cells and expressed in percentage as shown following: 
𝐹𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 (%) = (
𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 𝑜𝑓 𝑡𝑟𝑒𝑡𝑎𝑡𝑒𝑑 𝑐𝑒𝑙𝑙𝑠
𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 𝑜𝑓 𝑢𝑛𝑡𝑟𝑒𝑡𝑎𝑡𝑒𝑑 𝑐𝑒𝑙𝑙𝑠
) × 100 Equation 4) 
 
Validation of UV-mediated ROS generation assay using DCFH-DA with a 
positive control  
Using the optimized conditions, 2×104 cells/well (optimal cell density) were seeded and 
incubated at 37°C in a 5% CO2 atmosphere. After an incubation of 24 hours, the medium 
was removed, the cells washed once with DPBS and different test compound concentrations 
were added for 1h and irradiated for 10 min with a plate control kept in dark under the same 
conditions. Then, the cells were washed and complete DMEM contain 50μM of DCFH-DA 
was added and incubated for 30min. After this, the cells were washed once with DPBS, fresh 
medium added and incubated. The fluorescence was measured at different times (30min, 
3h and 24h) using a fluorescence plate reader with a baseline of 485 nm excitation and 
530nm emission. 
The results were expressed as referred above (equation 4) 
 
The effects of quinine HCl and irradiation in total GSH (tGSH) using (DTNB)-
GSSG reductase-recycling assay 
The cells was seeded into 6-well plates and incubated for 24h. Afterwards, the quinine 
HCl was added at 1260 µM for 1h and irradiated for 10min with an equivalent plate kept in 
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dark. The cells were washed and after an incubation time of 22h, cells were lysed with 5% 
perchloric acid (HClO4, w/v) scrapped/precipitated and centrifuged at 13,000 x g for 10 min 
at 4 °C. Then, the supernatant of cell lysates was collected and stored at -80°C for further 
determination. The pellet obtained was resuspended in 0.3 M sodium hydroxide (NaOH) 
with 1:8 dilution for a final volume of 200 µL and used for protein quantification, 
determined by the Lowry assay. The thawed acidic supernatant, after a 1:8 dilution with 
HClO4 (final volume of 200 µL), was neutralized with 0.76 M potassium bicarbonate 
(KHCO3) in a 1:1 proportion and centrifuged for 5 min at 13,000 x g at 4°C. To calculate the 
total glutathione (tGSH), 100 µL of the neutralized supernatants were transferred, in 
triplicate, to a 96-well plate. After this, 65 µL of freshly prepared reagent with 0.24 mM 
NADPH and 1.3 mM 5,5-dithio-bis(2-nitrobenzoic acid) (DTNB) in phosphate buffer (71.5 
mM Na2HPO4, 71.5 mM NaH2PO4 and 0.63 mM EDTA, pH 7.5) were added. Afterwards, 
the plates were incubated for 15 min, at 30 °C and then 40 µL per well of a freshly prepared 
10 IU/mL glutathione reductase solution in phosphate buffer were added. Finally, the 
stoichiometric formation of TNB was followed in kinetic mode (at 30 °C), with pre-
measurement mixing, every 10 s for 3 min at 415 nm, and compared with a standard curve. 
The results were normalized to the total protein amount, and the final results were 
expressed as nmol tGSH per mg protein. 
 
Study of EHMC and TiO2 combination under irradiation 
An additional analysis was performed in partnership with FEUP research group, where 
photoproducts and compounds combinations was evaluated. An aqueous solutions of 
EHMC 8.0x10-5 M (10 % v/v in acetonitrile) were prepared in the absence and presence of 
TiO2-P25 (1 g/L, Evonik Degussa). Blank solutions of aqueous TiO2-P25 (1 g/L, 10% v/v in 
acetonitrile) and of water (10% v/v in acetonitrile) were also prepared. Aqueous solution of 
the mixture (EHMC+TiO2-P25, 10% v/v in acetonitrile) was irradiated with one UV LED 
(10 W, emission at 385 nm) during 30 min. 5 mL of each solution was taken, filtered with 
0.45 µm PTFT filters and EHMC was extracted with 5 mL of acetonitrile. These solutions 
were then used for NRU cytotoxicity assay. 
 
3.2.4. Statistical analysis 
All the data are presented as mean ± standard deviation (SD) of at least three 
independent experiments. Statistical analysis was performed using the SPSS software (v 
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23.0; IBM, Armonk, NY, USA). To confirm the normality and homogeneity of variance 
Shapiro-Wilk and Levene tests were used, respectively, and after this the One-way analysis 
of variance (ANOVA) followed by the Dunnett post hoc test (comparison to negative control- 
cells with solvent) was performed. Graphs were generated with the software GraphPad 
Prism for Windows (version 6.0; GraphPad Software, Inc., USA). 
 
4. Results and discussion 
4.1. HaCat cell line characterization 
According with the graph shown below (Figure 24), the doubling time for HaCaT cell line 
was 22.18 ± 4.47 h. A doubling time of 26 hours is reported in literature (175), thus 
confirming our results. 
 
Figure 24. Determination of HaCaT cells doubling time by linear regression analysis. Data are presented 
as mean ± SD (n=3). 
 
4.2. ROS generation assay  
4.2.1. Solvent control 
The fluoresence range of all solvents used for the evaluation of ROS generation at 24h 
compound exposure is depicted in Figure 25. These solvent controls did not show a 
statistical significant difference relative to the negative controls (untreated cells; p≥ 0.05). 
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Figure 25. Fluorescence of HaCaT cell line exposed to solvent control by the Neutral Red by the DCFH-DA 
assay. Data are presented as mean ± SD (n=3). Data were analysed using One-way ANOVA with Dunnett 
post hoc test. 
 
4.2.2. ROS generation assay optimization 
As referred above, an optimization of the ROS generation assay was performed by 
studying the optimal cell density, and the concentration and the incubation time with the 
DCFH-DA probe. From the results obtained (Figure 26) a density of 2x105 cells/well and a 
concentration of DCFH-DA of 50 µM seemed to be the ideal conditions for the ROS 
generation assay, since the fluorescence signal was high enough to ensure appropriate 
sensitivity. Regarding the incubation time with the DCFH-DA probe, a significant difference 
between the data at 30min and 1h was not evident so, in order to decrease the duration of 
the assay, 30 min incubations were chosen for the final procedure. The difference between 
the two positive control (H2O2) concentrations is not relevant, a slight increase of 
fluorescence with 400µM was observed. 
             
        
Figure 26. Optimization of ROS generation assay with fluorescence regarding cell density, DCFH-DA 
concentration, incubation time and positive control (H2O2) concentration. (A) 1h with DCFH-DA and H2O2 
400μM (B) 1h with DCFH-DA and H2O2 700μM (C) 30min with DCFH-DA and H2O2 400μM and (D) 30min 
with DCFH-DA and H2O2 700μM. Data are presented as mean ± SD (n=3). 
A) B) 
D) C) 
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4.2.3. ROS generation using DCFH-DA 
Positive controls 
Hydrogen peroxide (H2O2)  
H2O2 induced an increase in fluorescence, yet this increase was only statistical significant 
different from the solvent control at 2000 µM (Figure 27). These data should be interpreted 
with caution given that hydrogen peroxide can interact with the DCFH-DA probe as was 
observed in an exploratory assay realized. This result needs further confirmation. 
 
Figure 27. ROS detection in HaCaT cell line exposed to H2O2 by the DCFH-DA assay. Data are presented 
as mean ± SD (n=3) relative to solvent control = 100 ± 20.8 (n=3). Data were analysed using One-way ANOVA 
with Dunnett post hoc test. * P<0.05 
 
Quinine HCl 
Quinine led to a concentration dependent decrease in ROS generation with statistical 
significance difference relative to solvent control from 6.3 mM (Figure 28). However, it 
should be noted that quinine apparently quenches fluorescence at the tested emition 
wavelenght as was observed in an exploratory study performed. This result needs further 
confirmation.  
 
Figure 28. ROS detection in HaCaT cell line exposed to Quinine HCl by the DCFH-DA assay. Data are 
presented as mean ± SD (n=3-5) relative to solvent control = 100 ± 11.7 (n=3). Data were analysed using One-
way ANOVA with Dunnett post hoc test. **P<0.01, ***P<0.001. 
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Raw materials under study 
1,2-DHX 
1,2-DHX did not present any significant increase in fluorescence signal relative to solvent 
control (Figure 29). 
 
Figure 29. ROS detection in HaCaT cell line exposed to 1,2-DHX by the DCFH-DA assay. Data are presented 
as mean ± SD (n=3) relative to solvent control= 100 ± 1.7 (n=3). Data were analyzed using One-way ANOVA 
with Dunnett post hoc test. 
 
5-MOP 
5-MOP did not promote ROS generation up to 300 µM with no statistical significance 
differences relative to solvent control (Figure 30). 
 
Figure 30. ROS detection in HaCaT cell line exposed to 5-MOP by the DCFH-DA assay. Data are presented 
as mean ± SD (n=3) relative to solvent control = 100 ± 1.7 (n=3). Data were analysed using One-way ANOVA 
with Dunnett post hoc test.      
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Acetylsalicilic acid 
ASA increased fluorescence up to 111101 µM (which was not concentration-dependent) 
with statistical significant difference relative to solvent control from 2775 µM (Figure 31). 
This result was possible due to interaction between ASA and the DCFH-DA probe and not 
due to an induced ROS generation in HaCaT cells as observed in an exploratory assay 
performed. However, this results needs further confirmation. 
 
Figure 31. ROS detection in HaCaT cell line exposed to ASA by the DCFH-DA assay. Data are presented as 
mean ± SD (n=3) relative to solvent control = 100 ± 11.7 (n=3). Data were analysed using One-way ANOVA 
with Dunnett post hoc test. * P<0.05, **P<0.01. 
 
Avobenzone 
Avobenzone did not cause any alteration in fluorescence signal as can be observed on 
Figure 32, with no statistical significance difference in comparison with solvent control. 
 
Figure 32. ROS detection in HaCaT cell line exposed to Avobenzone by the DCFH-DA assay. Data are 
presented as mean ± SD (n=4) relative to solvent control = 100 ± 17 (n=3). Data were analysed using One-
way ANOVA with Dunnett post hoc test. 
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C. sativa extract 
The C. sativa extract demonstrated a concentration dependent fluorescence increase, 
with statistical significant difference relative to solvent control from 250 µg/mL (Figure 33). 
This result may be due to compound fluorescence interference as showed in an exploratory 
assay performed. This result must be confirmed in the future. 
 
Figure 33. ROS detection in HaCaT cell line exposed to C. sativa extract by the DCFH-DA assay. Data are 
presented as mean ± SD (n=4) relative to solvent control = 100 ± 3.7 (n=3). Data were analyzed using One-
way ANOVA with Dunnett post hoc test. * P<0.05, **P<0.01, ***P<0.001 data are significant. 
 
Chlorpromazine  
CPZ did not reveal fluorescence increases, with  no statistical significance difference 
relative to solvent control (Figure 34). 
 
Figure 34. ROS detection in HaCaT cell line exposed to CPZ by the DCFH-DA assay. Data are presented as 
mean ± SD (n=4) relative to solvent control = 100 ± 20.8 (n=3). Data were analysed using One-way ANOVA 
with Dunnett post hoc test. 
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Diclofenac 
Diclofenac demonstrated a concentration dependent fluorescence increase, with 
statistical significance difference relative to solvent control from 500 µM (Figure 35). This 
result can has a compound fluorescence interference as observed in a exploratory assay 
realized and needs further confirmation. 
 
Figure 35. ROS detection in HaCaT cell line exposed to Diclofenac by the DCFH-DA assay. Data are 
presented as mean ± SD (n=4) relative to solvent control = 100 ± 1.7 (n=3). Data were analysed using One-
way ANOVA with Dunnett post hoc test. **P<0.01, ***P<0.001 
 
EHMC 
EHMC did not promote an increase in fluorescence, with no statistical significance 
difference relative to solvent control (Figure 36). 
 
Figure 36. ROS detection in HaCaT cell line exposed to EHMC by the DCFH-DA assay. Data are presented 
as mean ± SD (n=3) relative to solvent control = 100 ± 11.7 (n=3). Data were analysed using One-way ANOVA 
with Dunnett post hoc test. 
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Hexachlorophene 
Hexachlorophene led to a concentration-dependent fluorescence increase, however only 
with statistical significance difference relative to solvent control from 245 µM (Figure 37). 
This increase may have a compound fluorescence interference and future confirmation 
must be realized. 
 
Figure 37. ROS detection in of HaCaT cell line exposed to Hexachlorophene by the DCFH-DA assay. Data 
are presented as mean ± SD (n=3-4) relative to solvent control 100 ± 1.7 (n=3). Data were analysed using One-
way ANOVA with Dunnett post hoc test. **P<0.01, ***P<0.001. 
 
Resveratrol 
Resveratrol induced a decrease in ROS generation, with statistical significance difference 
relative to solvent control from 100 µM (Figure 38). However, this decrease may be related 
to interactions between RSV with medium and the DCFH-DA probe as observed in a 
exploratory assay performed. This result needs further confirmation. 
 
Figure 38. ROS detection in HaCaT cell line exposed to RSV by the DCFH-DA assay. Data are presented as 
mean ± SD (n=3-6) relative to solvent control = 100 ± 1.7 (n=3). Data were analysed using One-way ANOVA 
with Dunnett post hoc test. * P<0.05, **P<0.01, ***P<0.001. 
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Sodium lauryl sulphate 
SLS evoked an increase in the measured fluorescence signal, with statistical significance 
difference relative to solvent control from 260 µM (Figure 39). However, also in this case, 
this result may result from an interaction of SLS with the DCFH-DA probe as observed in 
an exploratory assay preformed. Thus, this result needs further confirmation. 
 
Figure 39. ROS detection in HaCaT cell line exposed to SLS by the DCFH-DA assay. Data are presented as 
mean ± SD (n=3-5) relative to solvent control = 100 ± 20.8 (n=3). Data were analysed using One-way ANOVA 
with Dunnett post hoc test. ***P<0.001. 
 
4.3. Neutral red uptake assay 
4.3.1. Solvent control 
The cytotoxicity of all solvents used  for the evaluation of phototoxic effects at 24h 
compound exposure is depicted in Figure 40. These solvent controls did not show a 
statistical significant difference relative to the negative controls (untreated cells; p≥ 0.05).  
 
Figure 40.  Cell viability of HaCaT cell line exposed to solvent control by the Neutral Red assay. Data are 
presented as mean ± SD (n=3). Data were analysed using One-way ANOVA with Dunnett post hoc test. 
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4.3.2. Neutral red uptake assay optimization 
As referred above, an optimization of NRU assay was performed, by studying the optimal 
cell density, NR concentration and incubation time with the NR solution. With regards to 
the NR concentration, the assay included macroscopic and microscopic observation.  
Crystal formation could be seen before filtering the 100 µg/mL solution, so the final 
concentration was not the desired one. Crystal formation in the well could be observed at 
concentrations higher than 330 µg/mL, as shown in Figure 41. 
 
Figure 41. Observation under inverted microscope of HaCaT cells incubated with 100 µg/mL NR solution 
(10X magnification). 
 
From the results obtained (Figure 42) a density of 2x104 cells/well, NR concentration of 
50 µg/mL and 3h incubation with the NR solution were selected as the ideal test conditions. 
Under these conditions, no formation of NR crystals was observed and the absorbance was 
high enough to ensure appropriate assay sensitivity. 
 
        
Figure 42. Optimization of NR uptake assay with absorbance regarding cell density, NR concentration 
and incubation time. (A) NR 33μg/mL (B) NR 50μg/mL (C) NR 100μg/mL and (D) NR 330μg/mL. Data are 
presented as mean ± SD (n=3-5). 
 
A) B) 
D) C) 
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Regarding the parameters optimized in a reported study, the NR concentration and 
incubation time, and exposure time of the tested compounds were identical to the majority 
of the studies conducted with this cell line. Cell densities varied from 5×103/well to 
1.5×105/well which encompasses the cell density selected in this study (2×104/ well). The 
type of radiation source and irradiation doses vary widely in the literature reports, with the 
majority of the tests conducted solely with UVA (176).  
 
4.3.3. Neutral red uptake cytotoxicity test 
Raw materials under study 
5-MOP 
The cytotoxicity study demonstrated that 5-MOP does not cause cell death up to 300 µM 
after 24h exposure, with no significative differences relative to solvent control detected 
(Figure 43). 
 
Figure 43. Cell viability of HaCaT cell line exposed to 5-MOP by the Neutral Red assay. Data are presented 
as mean ± SD (n=9-13) relative to solvent control = 100 ± 6.3. Data were analysed using One-way ANOVA 
with Dunnett post hoc test.  
 
Acetyl salicylic acid 
Acetyl salicylic acid (ASA) was found to be non cytotoxic to HaCaT cells until 1100 µM 
with no statistical significate difference relative to control (Figure 44). 
 
Figure 44. Cell viability of HaCaT cell line exposed to ASA by the Neutral Red assay. Data are presented 
as mean ± SD (n=5) relative to solvent control = 100 ± 11.9 (n=3). Data were analysed using One-way ANOVA 
with Dunnett post hoc test. 
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Avobenzone 
The UV-filter avobenzone did not demonstrate cytotoxic effects up to 200 µM. However 
it is possible to observe a decrease in cell viability between 10 and 100 µM and than a 
stabilization, but not with stastistical significance relative to control (Figure 45). 
 
Figure 45. Cell viability of HaCaT cell line exposed to Avobenzone by the Neutral Red assay. Data are 
presented as mean ± SD (n=3) relative to solvent control = 100 ± 6.3 (n=3). Data were analysed using One-
way ANOVA with Dunnett post hoc test.  
 
Chlorpromazine 
CPZ promoted a decrease in HaCaT viability with an IC50 of 41.67 ± 2.62 µM, with 
statistical significance difference relative to solvent control from 35 µM (Figure 46). 
 
Figure 46. Cell viability of HaCaT cell line exposed to CPZ by the Neutral Red assay. Data are presented as 
mean ± SD (n=6) relative to solvent control = 100 ± 12.5 (n=3). Data were analysed using One-way ANOVA 
with Dunnett post hoc test. ***P<0.001. 
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Diclofenac 
The cytotoxicity of diclofenac only presented a significant difference from controls from 
500 µM and the IC50 could not be calculated (Figure 47). 
 
Figure 47. Cell viability of HaCaT cell line exposed to Diclofenac by the Neutral Red assay. Data are 
presented as mean ± SD (n=3) relative to solvent control = 100 ± 6.3 (n=3). Data were analysed using One-
way ANOVA with Dunnett post hoc test. **P<0.01, ***P<0.001. 
 
EHMC 
EHMC had a IC50 for cytotoxicity of 547.68 ± 88.48 µM, with statistical significance 
difference relative to solvent control from 345 µM (Figure 48). 
 
Figure 48. Cell viability of HaCaT cell line exposed to EHMC by the Neutral Red assay. Data are presented 
as mean ± SD (n=3-7) relative to solvent control = 100 ± 11.9 (n=3). Data were analysed using One-way 
ANOVA with Dunnett post hoc test. ***P<0.001. 
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Hexachlorophene 
Hexachlorophene presented an IC50 of 156.66 ± 19.27 µM, with statistical significance 
difference relative to solvent control from 122 µM (Figure 49). 
 
Figure 49. Cell viability of HaCaT cell line exposed to Hexachlorophene by the Neutral Red assay. Data are 
presented as mean ± SD (n=3-20) relative to solvent control = 100 ± 6.3 (n=3). Data were analysed using One-
way ANOVA with Dunnett post hoc test. * P<0.05, ***P<0.001. 
 
Hydrogen peroxide 
With respect to the study of the cytotoxicity of H2O2 the IC50 determined was 243.31 ± 
59.64 µM, with statistical significance difference relative to solvent control from 200 µM 
(Figure 50). 
 
Figure 50. Cell viability of HaCaT cell line exposed to H2O2 by the Neutral Red assay. Data are presented 
as mean ± SD (n=3-8) relative to solvent control = 100 ± 26.6 (n=3). Data were analysed using One-way 
ANOVA with Dunnett post hoc test. **P<0.01, ***P<0.001. 
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Quinine HCl 
The cytotoxicity study of quinine HCl present a IC50 of 787.75 ± 222.73 µM, with 
statistical significance difference relative to solvent control from 504 µM (Figure 51). 
 
Figure 51. Cell viability of HaCaT cell line exposed to Quinine HCl by the Neutral Red assay. Data are 
presented as mean ± SD (n=5) relative to solvent control = 100 ± 11.9 (n=3). Data were analysed using One-
way ANOVA with Dunnett post hoc test. * P<0.05, ***P<0.001. 
 
Sodium lauryl sulphate 
SLS presented an IC50 of 221.09 ± 26.13 µM, with statistical significance difference 
relative to solvent control from 260 µM (Figure 52). 
 
Figure 52. Cell viability of HaCaT cell line exposed to SLS by the Neutral Red assay. Data are presented as 
mean ± SD (n=3-6) relative to solvent control = 100 ± 27.5 (n=3). Data were analysed using One-way ANOVA 
with Dunnett post hoc test. ***P<0.001. 
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4.4. Implementation and validation of a phototoxicity assay 
using HaCaT 
4.4.1. Solvent control 
The cytotoxicity of all solvents used  for the evaluation of phototoxic effects, in the 
presence and absence of irradiation, with 1h of compound exposure is depicted in Figure 
53. These solvent controls did not show a statistical significant difference relative to the 
negative controls (untreated cells; p≥ 0.05).  
   
Figure 53. Cell viability of HaCaT cell line exposed to solvent control at plate A) not irradiate and B) 
irradiate by the Neutral Red assay. Data are presented as mean ± SD (n=3). Data were analysed using One-
way ANOVA with Dunnett post hoc test.  
 
4.4.2. Spectral absorption 
  All the compounds exhibited absorption in the 290-700 nm range, which is a 
primary condition before conducting phototoxicity tests (Figures 54-67). 
 
          
Figure 54. C. sativa spectral absorption     Figure 55. CPZ spectral absorption 
A) B) 
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Figure 56. Quinine HCl spectral absorption          Figure 57. SLS spectral absorption 
   
Figure 58. Hexachlorophene spectral absorption          Figure 59. ASA spectral absorption 
              
Figure 60. Diclofenac spectral absorption           Figure 61. EHMC spectral absorption 
               
Figure 62. 1,2-DHX spectral absorption           Figure 63. 5-MOP spectral absorption 
0
1.3
0.5
1
250 700300 400 500 600
Abs
Wavelength [nm]
-0.1
0.7
0
0.2
0.4
0.6
250 700300 400 500 600
Abs
Wavelength [nm]
-0.1
0.6
0
0.2
0.4
250 700300 400 500 600
Abs
Wavelength [nm]
-0.1
1.9
0.5
1
1.5
250 700300 400 500 600
Abs
Wavelength [nm]
-0.1
1.1
0
0.5
1
250 700300 400 500 600
Abs
Wavelength [nm]
-0.1
0.9
0
0.2
0.4
0.6
0.8
250 700300 400 500 600
Abs
Wavelength [nm]
Bruna Maciel 
63 
 
 
                
Figure 64. Avobenzone spectral absorption           Figure 65. RSV spectral absorption. 
                 
Figure 66. H2O2 spectral absorption             Figure 67. RGS spectral absorption 
 
 
4.4.3. Optimization of irradiation conditions 
The radiation intensity recommended by the OCDE 432 guideline is 1.7mW/cm2, which 
corresponded to the irradiation obtained with the lamp positioned at 46.5cm height (Figure 
68). During the irradiation period (1h), the temperature achieved using a water-cooling 
system varied between 29 and 32°C, maintaining the cell viability (Figure 69). Under these 
conditions, UV exposures longer than 15 min were cytotoxic for HaCaT cells. An irradiation 
period of 10 min was considered the optimal irradiation time, since it afforded cell viabilities 
of 77 ± 2.94% (Figure 70). Therefore, we assumed that this irradiation time provided 
evidence for the phototoxic potential of the test compounds without significantly 
compromising cell viability. The UVA/UVB lamp used has some advantages regarding the 
most commonly used UVA lamps, since it contemplates the UVA and UVB wavelength, 
better simulating the solar spectrum. Besides this, it is an inexpensive choice. 
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Figure 68. UVA/UVB Osram lamp   Figure 69. Temperature achieved using a water-cooling. 
and radiometer used in this work. 
 
Figure 70. Viability of HaCaT cells exposed to UVA/UVB radiation, determined by the Neutral Red assay. 
Data are presented as mean ± SD (n=3-12). Data were analysed using One-way ANOVA with Dunnett post 
hoc test. * P<0.05, **P<0.01, ***P<0.001. 
 
4.4.4. Neutral red uptake phototoxicity test 
Positive controls 
5-MOP 
5-MOP is a positive control in phototoxicity testing. Under our test conditions, the 
IC50(+irr) value determined was 3.8 ± 0.24 µM, with statistical significant differences 
relative to solvent control from 2.5 µM. The IC50(-irr) could not be obtained due to 
compound solubility limitations, therefore, it is possible to conclude that the IC50(-irr) is 
higher than 300µM (Figure 71). Thus, the PIF was calculated with the maximum 
concentration tested (300 µM), and not with the IC50 values. With this calculation, the 
estimated PIF was 78.8 ± 5.11, which it is in accordance with positive phototoxic potential.  
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Figure 71. Cell viability of HaCaT cell line exposed to 5-MOP, determining the phototoxicity by the Neutral 
Red assay. –irr: plate not irradiate. +irr: plate irradiate. Data are presented as mean ± SD (n=4-5) relative 
to solvent control, with (+irr)= 100 ± 20.5 (n=3) and (-irr)= 100 ± 16.9 (n=3). Data were analysed using One-
way ANOVA with Dunnett post hoc test. ***P<0.001. 
 
We have compared our data with the results reported for mice BALB/c 3T3 fibroblasts: 
IC50(+irr) was 7.4 µM, IC50(-irr) could not be obtained, and PIF calculated as referred 
above, was 62.5 (123). It can be concluded that keratinocytes are probably more sensitive to 
5-MOP phototoxicity than fibroblasts. 
The NRU Phototoxicity test has already been performed with HaCaT cells (176, 177).  In 
studies with 5-MOP and 250 mJ/cm2 UVA, an IC50(+irr) value of 190 µM was obtained 
(178), which is markedly higher than the ones obtained in the present study (3.8 µM). 
However in the mentioned study, it was used solely UVA light in a dose 4 times lower that 
the used in the present work. 
 
Chlorpromazine 
Chlorpromazine is the most used positive control for phototoxicity assays. The obtained 
results corroborate this fact. The IC50(-irr) was 193.5 ± 13.74 µM, with statistical significant 
difference relative to solvent control from 140.9 µM and IC50 (+irr) was 6.93 ± 1.46 µM 
with statistical significant difference relative to solvent control from 8.5 µM, thereby 
obtaining a PIF of 23.30 ± 2.69 (Figure 72). 
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Figure 72. Cell viability of HaCaT cell line exposed to CPZ, determining the phototoxicity by the Neutral 
Red assay. –irr: plate not irradiate. +irr: plate irradiate Data are presented as mean ± SD (n=3-6) relative 
to solvent control, with afforded a cell viability of (+irr)= 100 ± 15.2 % (n=3) and (-irr)= 100 ± 7.8 (n=3). Data 
were analysed using One-way ANOVA with Dunnett post hoc test. ***P<0.001. 
 
Comparing these results with those already reported for BALB/c 3T3 fibroblasts, when 
IC50(-irr) was 34.49 µM, IC50(+irr) was 1.2 µM and PIF was 9.2 (123), the human 
keratinocyte cell line manifested less sensitivity to chlorpromazine, which may be due to the 
powerful antioxidant system of these cells, since ROS generation with CPZ was reported in 
literature to mitochondrial membrane potential assay. 
 In another HaCaT study reported in literature, the IC50(+irr) was 15.82 µM with 
250 mJ/cm2 UVA (178), which is markedly higher than the values obtained in the present 
study (6.93 µM). However the mentioned study used solely UVA light in a dose 4 times 
lower that the one used in the present work. The PIF values described in literature were 49 
(179) and 16.7 (180). Taking together, these findings support the validity of the methodology 
implemented herein but reinforce the importance of careful comparisons when different 
test conditions such as cell density, irradiation sources and doses are used. 
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Quinine HCl 
Quinine is a positive control in phototoxicity assays. In the present study its IC50(-irr) 
was 4269.88 ± 734.08 µM, its IC50 (+irr) was 1293.42 ± 240.97 µM, both with statistical 
significance difference relative to solvent control from 1259 µM and a PIF of 2.09 ± 0.85. 
Quinine was thus classify as probably phototoxic (Figure 73).  
In a study conducted with BALB/c 3T3 fibroblasts the PIF was 15.7 (59). Also in this case, 
the differences observed in our keratinocytes may be possibly justified by their powerful 
antioxidant system, since quinine was reported to produce 6-methoxy-quinoline-4-
ylmethyl-oxonium as photoproduct and to generate ROS, such as 1O2, O2(•-) and (•)OH 
under UV exposure (181). Finally, this conclusion can be corroborated by the GSH assay 
data reported in section 4.4.7. 
 
Figure 73. Cell viability of HaCaT cell line exposed to Quinine HCl, determining the phototoxicity by the 
Neutral Red assay. –irr: plate not irradiate. +irr: plate irradiate Data are presented as mean ± SD (n=3-5) 
relative to solvent control, with (+irr)= 100 ± 20.7 (n=3) and (-irr)= 100 ± 12.0 (n=3). Data were analysed 
using One-way ANOVA with Dunnett post hoc test. * P<0.05, **P<0.01, ***P<0.001. 
 
 
Negative controls 
Acetyl salicylic acid (ASA) 
This compound is commonly used as a negative control in phototoxicity evaluations. Our 
data corroborat this fact (Figure 74). However, the IC50 and PIF could not be determinated 
since no statistically significant differences relative to control were observed at any of the 
tested concentrations. As an alternative, the MPE determination could provide relevant 
information. 
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Figure 74. Cell viability of HaCaT cell line exposed to ASA, determining the phototoxicity by the Neutral 
Red assay. –irr: plate not irradiate. +irr: plate irradiate Data are presented as mean ± SD (n=5) relative to 
solvent control, with (+irr)= 100 ± 20.7 (n=3) and (-irr)= 100 ± 12.0 (n=3). Data were analysed using One-
way ANOVA with Dunnett post hoc test. 
 
Hexachlorophene 
Hexachlorophene is also a negative control commonly used in phototoxicity assays. In 
this study, the IC50(-irr) for this compound was 356.61 ± 49.41 µM, with statistical 
significance difference relative to solvent control from 307 µM and IC50(+irr) was 327.18 ± 
47.26 µM, with statistical significance difference relative to solvent control from 491 µM, 
with a calculated PIF value of 1.03 ± 0.08 (Figure 75). Thus it was confirmed that  
hexachlorophene is not phototoxic also in our keratinocyte cell model. 
In 3T3 NRU-PT with BALB/c 3T3 fibroblasts, IC50(-irr) was 27.03 µM, IC50(+irr) was 
22.86 and a PIF of 1.2, indicating that human keratinocytes are less sensitive to 
Hexachlorophene than fibroblasts. 
 
Figure 75. Cell viability of HaCaT cell line exposed to Hexachlorophene, determining the phototoxicity by 
the Neutral Red assay. –irr: plate not irradiate. +irr: plate irradiate Data are presented as mean ± SD (n=3-
8) relative to solvent control, with (+irr)= 100 ± 20.5 (n=3) and (-irr)= 100 ± 16.9 (n=3). Data were analysed 
using One-way ANOVA with Dunnett post hoc test. * P<0.05, **P<0.01, ***P<0.001. 
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Sodium Lauryl Sulphate 
The most commonly used negative control in the NRU-PT assay is SLS and the present 
study confirmed its negative phototoxicity. The IC50(-irr) was 559.92 ± 57.74 µM, 
Ic50(+irr) was 519.73 ± 231.94 µM, both with statistical significance difference relative to 
solvent control from 347 µM. The corresponding PIF was 1.25 ± 0.53 (Figure 76).  
From data reported in the literature for SLS with BALB/c 3T3 fibroblasts, an IC50(-irr) 
of 124.84 µM, an IC50(+irr) of 112.7 µM and a PIF of 1.2 were found, which may reflect a 
lower sensitivity of HaCaT to SLS. 
 
Figure 76. Cell viability of HaCaT cell line exposed to SLS, determining the phototoxicity by the Neutral 
Red assay. –irr: plate not irradiate. +irr: plate irradiate Data are presented as mean ± SD (n=3-6) relative 
to solvent control, with (+irr)= 100 ± 27.4 (n=3) and S-irr)= 100 ± 22.3 (n=3). Data were analysed using One-
way ANOVA with Dunnett post hoc test. ***P<0.001. 
 
Overall, the positive and negative controls validate the established procedure for the 
NRU-PT assay with HaCat cell line. However, as mentioned above, the Quinine HCl is not 
an adequate positive control.  
 
Raw materials 
1,2-DHX 
In the 1,2-DHX phototoxicity assay the IC50 values and consequently the PIF could not 
be obtained, and no statistical significant difference relative to solvent control was observed. 
The compound does not seem to be phototoxic up to 200 µM (Figure 77). Also in this case 
MPE determination could provide additional confirmation of the lack of phototoxic 
properties. 
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Figure 77. Cell viability of HaCaT cell line exposed to 1,2-DHX, determining the phototoxicity by the Neutral 
Red assay. –irr: plate not irradiate. +irr: plate irradiate Data are presented as mean ± SD (n=3) relative to 
solvent control, with (+irr)= 100 ± 20.5 (n=3) and (-irr)= 100 ± 16.9 (n=3). Data were analysed using One-
way ANOVA with Dunnett post hoc test. 
 
Avobenzone 
Avobenzone is a UV- filter with a positive result in 3T3 NRU-PT with fibroblasts but not 
in human tests (140). The obtained results did not allow to determine the IC50 and PIF, yet 
the data seem to indicate the absence of phototoxicity up to 200 µM, with no statistical 
significant differences relative to solvent control detected (Figure 78). Therefore, these 
results can further support a good correlation of the procedure conducted with HaCaT cells 
to in vivo tests. Again for this compound the MPE calculation would be recommended.  
The results reported with BALB/c 3T3 fibroblasts correspond to these results, when the 
IC50s and PIF could not be obtained (123). 
 
Figure 78. Cell viability of HaCaT cell line exposed to Avobenzone, determining the phototoxicity by the 
Neutral Red assay. –irr: plate not irradiate. +irr: plate irradiate Data are presented as mean ± SD (n=3) 
relative to solvent control, with (+irr)= 100 ± 20.5 (n=3) and (-irr)= 100 ±16.9 (n=3). Data were analysed 
using One-way ANOVA with Dunnett post hoc test.  
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C. sativa leaf extract 
The study of C. sativa phototoxicity revealed a IC50(-irr) of 419.97 ± 76.91 µg/mL, with 
statistical significance difference relative to solvent control from 250 µg/mL and a 
IC50(+irr) of 193.22 ± 3.82 µg/mL with statistical significance difference relative to solvent 
control from 100 µg/mL (Fogure 79). A PIF of 2.18 ± 0.42 µg/mL was obtained. In 
conclusion this is a probable phototoxic agent. Nevertheless, the MPE should be calculated 
to confirm this result. 
 
Figure 79. Cell viability of HaCaT cell line exposed to C.sativa, determining the phototoxicity by the Neutral 
Red assay. –irr: plate not irradiate. +irr: plate irradiate Data are presented as mean ± SD (n=3-4) relative 
to solvent control, with (+irr)= 100 ± 14.9 (n=3) and (-irr)= 100 ± 6.3 (n=3). Data were analysed using One-
way ANOVA with Dunnett post hoc test. ***P<0.001. 
 
Chlorogenic acid (CA) 
A preliminary test (n=1) was conducted for CA where it was possible to observe 
differences between the irradiate and non irradiation conditions yet these were not very 
marked. It is impossible determine the IC50 at this concentration range and consequently 
the PIF. In conclusion, CA is possibly not phototoxic up to 500 µM, but additional assays 
should be performed, followed by calculation of MEP (Figure 80). 
 
Figure 80. Cell viability of HaCaT cell line exposed to CA, determining the phototoxicity by the Neutral Red 
assay. –irr: plate not irradiate. +irr: plate irradiate. Data are presented as mean (n=1). 
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Comparing these results with concentration in C. sativa extract, which has 2.23 mg/g of 
CA and this value correspond to 1.115 µg in 500 µg (maximum concentration evaluated) of 
extract. CA was tested up to 500 µM that correspond to 177.16 µg/mL, thus the CA present 
in C. sativa extract may not be responsible by phototoxic potential of extract. To confirm 
this more phototoxicity assays with CA must be performed, as well as evaluated the 
phototoxic potential of another constituents of C. sativa extract and MPE calculation. 
 
Chlorogenic acid persulfate (CAP) 
A preliminary test (n=2) was conducted for CAP where it was observed a small difference 
between irradiate ant non irradiation conditions. Is was impossible to calculate the IC50 at 
this concentration range, and therefore it can only be concluded that CAP is possibly not 
phototoxic at these concentrations and under the present test conditions (Figure 81). To 
confirm these results, additional assays must be performed and the MPE index should be 
calculated. 
 
Figure 81. Cell viability of HaCaT cell line exposed to CAP, determining the phototoxicity by the Neutral 
Red assay. –irr: plate not irradiate. +irr: plate irradiate Data are presented as mean ± SD (n=2). 
 
Diclofenac 
As referred above, this compound is known as phosensitizer and was expected to perform 
as a phototoxic compound in this study. However, the IC50 values could not be obtained 
and consequently the PIF value was not calculated. However, our data analysis showed that 
the compound does not seem to present phototoxic potential up to 1000 µM, since no 
statistical significance difference relative to solvent control was observed (Figure 82). To 
confirm this assumption the MPE determination should be performed. 
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Figure 82. Cell viability of HaCaT cell line exposed to Diclofenac, determining the phototoxicity by the 
Neutral Red assay. –irr: plate not irradiate. +irr: plate irradiate Data are presented as mean ± SD (n=3) 
relative to solvent control, with (+irr)= 100 ± 20.5 (n=3) and (-irr)= 100 ± 16.9 (n=3). Data were analysed 
using One-way ANOVA with Dunnett post hoc test. 
 
EHMC 
The UV-filter EHMC is a photo-unstable compound that can form photoproducts under 
UV irradiation. In the present phototoxicity assay the IC50(-irr) obtained was 635.6 ± 47.85 
µM and IC50(+irr) was 437.84 ± 129.5 µM, both with statistical significance difference 
relative to solvent control from 5160 µM, which led to a PIF of 1.58 ± 0.45 (Figure 83). In 
conclusion, EHMC was not a phototoxic compound under our test conditions. 
 
Figure 83. Cell viability of HaCaT cell line exposed to EHMC, determining the phototoxicity by the Neutral 
Red assay. –irr: plate not irradiate. +irr: plate irradiate Data are presented as mean ± SD (n=3-7) relative to 
solvent control, with (+irr)= 100 ± 20.7 (n=3) and (-irr)= 100 ± 12.0 (n=3). Data were analysed using One-
way ANOVA with Dunnett post hoc test. * P<0.05, **P<0.01, ***P<0.001. 
 A negative result has been already obtained with BALB/c 3T3 fibroblasts, but the 
IC50 values and PIF could not be obtained in that study, where the maximum concentration 
tested was 344 µM (123). 
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In order to study the cytotoxicity of EHMC photoproducts  the NRU assay was performed 
for EHMC irradiated in the presence of  TiO2 P25, a known photocatalist  and a UV-filter 
frequently used in combination with EHMC (182). This assay was performed twice, with 
two different compounds production, corresponding to two different graphs present below. 
It can be concluded that the solvent (acetonitrile- ACN) does not affect cell viability and 
that 100x, 30x and 15x dilutions did not present significant differences relative to solvent 
control. At the 10x dilution and when TiO2 is present, the cellular viability decreased 
significantly relative to solvent control. In the absence of TiO2 this effect did not occur 
(Figure 84 and 85). Therefore, is possible to conclude that citotoxicity is caused by TiO2 or 
its photoproducts and not by EHMC or its phototproducts, ensuring the safety of EHMC as 
sunscreen. 
  
Figure 84. Cell viability of HaCaT cell line exposed to first analysed samples by the Neutral Red assay. Data 
are presented as mean ± SD (n=3-7). Data were analysed using One-way ANOVA with Dunnett post hoc test. 
X- diluition; 1-10% ACN. (solvent control); 2- EHMC + 10% ACN.; 3- EHMC  + P25 (TiO2) + 10% ACN. (0 min 
irr); 4- EHMC + P25 (TiO2) + 10% ACN. (30 min irr); 5- P25 (TiO2) + 10% ACN; ***P<0.001.  
 
Figure 85. Cell viability of HaCaT cell line exposed to second analysed samples by the Neutral Red assay. 
Data are presented as mean ± SD (n=3-6). Data were analysed using One-way ANOVA with Dunnett post hoc 
test. X- diluition; 1- EHMC + 10% ACN.; 2- EHMC  + P25 (TiO2) + 10% ACN. (0 min irr); 3- EHMC + P25 (TiO2) 
+ 10% ACN. (30 min irr); 4- EHMC + P25 (TiO2) + 10% ACN. (60 min irr); 5- P25 (TiO2) + 10% ACN; 6- 10% 
ACN. (solvent control)***P<0.001. 
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Hydrogen peroxide 
Since H2O2 was used as a positive control in the ROS assay, the phototoxicity of H2O2 
was also evaluated. The IC50(-irr) was 302.42 ± 177.57 µM and the IC50 (+irr) was 178.52 
± 52.27 µM, both with statistical significance difference relative to solvent control from 100 
µM, leading to a PIF of 1.37 ± 0.82 (Figure 86). In was concluded that hydrogen peroxide is 
a not phototoxic compound. 
 
Figure 86. Cell viability of HaCaT cell line exposed to H2O2, determining the phototoxicity by the Neutral 
Red assay. –irr: plate not irradiate. +irr: plate irradiate Data are presented as mean ± SD (n=3-9) relative 
to solvent control, with (+irr)= 100 ± 40.2 (n=3) and (-irr)= 100 ± 32.9 (n=3). Data were analysed using One-
way ANOVA with Dunnett post hoc test. * P<0.05, **P<0.01, ***P<0.001. 
 
RSV and its derivatives 
RSV isomerizes after UV  exposure. Regrading  its phototoxicity, is a not phototoxic 
compound, since the IC50(-irr) was 1187 ± 186.54 µM, yet with no statistical significance 
difference relative to solvent control and IC50(+irr) was 821 ± 142.24 µM, with statistical 
significance difference relative to solvent control from 750 µM, leading to a PIF of 1.48 ± 
0.19 (Figure 87). Thus, the RSV isomeres formation did not influence the phototoxic 
potential. 
 
Figure 87. Cell viability of HaCaT cell line exposed to RSV, determining the phototoxicity by the Neutral 
Red assay. –irr: plate not irradiate. +irr: plate irradiate Data are presented as mean ± SD (n=3-6) relative 
to solvent control, with (+irr)= 100 ± 20.5 (n=3) and (-irr)= 100 ± 16.9 (n=3). Data were analysed using One-
way ANOVA with Dunnett post hoc test. * P<0.05, **P<0.01. 
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A preliminary test (n=1) was conducted for RGS where the observation of differences 
between the irradiate and non irradiation conditions was possible, yet these were not very 
marked. The IC50 calculation is not possible at this concentration range and consequently 
the same to PIF. Therefore, RGS is possibly not phototoxic up to 500 µM, but additional 
assays should be performed, followed by calculation of MEP (Figure 88). 
 
Figure 88. Cell viability of HaCaT cell line exposed to RGS, determining the phototoxicity by the Neutral 
Red assay. –irr: plate not irradiate. +irr: plate irradiate. 
 
HaCat keratinocytes were less sensitive to photo-irritant compounds when compared to 
3T3 fibroblasts, as was previously reported (176). However, for some specific purposes, like 
cosmetic’s safety assays, keratinocytes are preferred since they are the first cells exposed to 
topical formulations and to the sun light. The 3T3 NRU phototoxicity test has been however 
validated by the ECVAM (European Centre for the Validation of Alternative Methods) in 
3T3 mouse fibroblasts due to the high correlation with in vivo tests. The modified neutral 
red assay developed herein was found to be a simple and reliable method for detecting 
phototoxic effects of reference agents.  
A photosafety survey has found that 85% of in vitro 3T3-NRU phototoxicity assay 
positives where negative when tested in vivo (183). A 86 % reduction in positive 3T3 NRU 
phototoxicity tests was also described by Liebsch et al (184) when using 3-D skin models. 
Based on our results, one possible explanation is the over-sensitivity of 3T3 fibroblasts when 
comparing with human keratinocytes.  
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 Table 9. Summary of phototoxicity, cytotoxicity and ROS generation results 
NA- Not applicable. NR- Not Realized; : increase in fluorescence;    : decrease in fluorescence; =- not 
different from negative control; *Tested at maximum solubility **IC50(-irr) could not be obtained 
 
4.4.5. Optimization of UV-mediated ROS generation assay using 
DCFH-DA with a positive control  
Since the DCFH-DA is sensitive to light (111), the probe was incubated before or after the 
irradiation and the ROS generation was evaluated using H2O2 as positive control. If the 
probe would be inactivated by the irradiation, then no ROS generation after H2O2 would be 
observed, as observed in Figure 89. In order to the washing and not washing steps with PBS 
again no fluorescence was detected. This is likely due to the cytotoxic effect induced by the 
Compound Ic50 (-irr) IC50 (+irr) PIF IC50 (24h) 
Fluorescence 
(%) 
1,2-DHX > 200 µM * > 200 µM * NA NR = 
5-MOP 3.8 ± 0.24 µM * > 300µM * 78.8 ± 5.11 ** > 300µM * = 
ASA > 1000 µM * > 1000 µM NA > 1000 µM * →
 
Avobenzone > 200 µM * > 200 µM * NA > 200 µM * = 
C. sativa 419.97 ± 76.91 μg/mL 193.22 ± 3.82 μg/mL 2.18 ± 0.42 NR →
 
CA > 500 µM * > 500 µM * NA NR NR 
CAP > 1700 µM * > 1700 µM * NA NR NR 
CPZ 193.5 ± 13.74 µM 6.93 ± 1.46 23.30 ± 2.69 41.67 ± 2.62 µM = 
Diclofenac > 1000 µM * > 1000 µM * NA > 1000 µM * →
 
EHMC 635.6 ± 47.85 µM 437.84 ± 129.5 µM 1.58 ± 0.45 547.68 ± 88.48 µM = 
H
2
O
2
 302.42 ± 177.57 µM 178.52 ± 52.27 µM 1.37 ± 0.82 243.31 ± 59.64 µM →
 
Hexochlorophene 356.61 ± 49.41 µM 327.18 ± 47.26 µM 1.03 ± 0.08 156.66 ± 19.27 µM 
→
 
Quinine HCl 4269.88 ± 734.08 µM 1293.42 ± 240.97 µM 2.09 ± 0.85 787.75 ± 222.73 µM 
→
 
RSV 1187 ± 186.54 µM 821 ± 142.24 µM 1.48 ± 0,19 NR →
 
SLS 559.92 ± 57.74 µM 519.73 ± 231.94 µM 1.25 ± 0.53 221.09 ± 26.13 µM →
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H2O2 test concentration or to the permeability of DCF (the fluorescent product of DCFH), 
which can leak out of cells (185). 
 
Figure 89. Fluorescence of HaCaT cell line exposed to positive control by the DCFH-DA assay with and 
without fresh medium replacement steps. DCFH-DA incubated before irradiation. +irr= plate irradiated. –
irr= plate not irradiated (n=1). 
 
When the DCFH-DA was added after the irradiation, no fluorescense increase was 
detected in the presence of cells (Figure 90). This result was difficult to interpret and can 
have many explanations such as the cell death at this H2O2 concentration mentioned above 
or the phenomenon of self-propagating redox-cycling reactions induced by the DCF radical 
(186) and the aducts formed by ROS with biological targets, both associated with  losses of 
fluorescence signal (58, 59). Therefore, this result requires future studies. In order to the 
fluorescence increase in non replaced fresh medium can be justified by interference of H2O2 
with DCFH-DA observed in an exploratory assay.  
 
Figure 90. Fluorescence of HaCaT cell line exposed to positive control by the DCFH-DA assay with and 
without fresh medium replacement steps. DCFH-DA incubated after irradiation. +irr= plate irradiate. –irr= 
plate not irradiate (n=1). 
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 For the purpose of increasing the fluorescence signal, an incubation time with 
DCFH-DA of 1h30m was studied. However, the fluorescence signal only increased slightly 
(Figure 91). Following this result, the DCFH-DA proper functioning was evaluated by 
testing the positive control addition before and after the incubation with DCFH-DA, which 
is incubated after irradiation. Beside that, the fluorescence was mesured at different times 
(3, 8 and 24h) (Figure 92 A). 
 
Figure 91. Fluorescence of HaCaT cell line exposed to positive control by the DCFH-DA assay with and 
without fresh medium replacement steps. DCFH-DA incubated for 1h30 after irradiation. +irr= plate 
irradiate. –irr= plate not irradiate (n=1). 
 
Figure 92. Fluorescence of HaCaT cell line exposed to positive control by the DCFH-DA assay A) before 
and B) after the DCFH-DA incubation. +irr= plate irradiate. –irr= plate not irradiate (n=1).            
 
 The addition of positive control before DCFH-DA did not demonstrate marked 
differences between irradiation and no irradiation conditions (Figure 92 A). However, the 
fluoresncence readimg at 8h showed  a transient increase, which can suggest  a relevant 
influence of time in probe oxidation. The addition of H2O2 after the DCFH-DA incubation 
demonstrated that DCFH-DA was performing well and able to detect reactive oxygen 
species (Figure 92 B). 
A) B) 
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Overall, these results may indicate cell death with the H2O2 concentration used or 
unsuitability of DCFH-DA to this assay. With the aim of clarify this result and optimize the 
UV-mediated ROS generation assay, a DCFH-DA kinetics assay should  be performed, once 
the reading at 24h can not be maximum fluorescence range. The use of another probe, such 
as versions of H2DCFDA must be evaluated. An increase in cell density may also increase 
the assay sensibility. 
 
4.4.6. Validation of UV-mediated ROS generation assay using DCFH-
DA with a positive control  
The validation of  the UV-mediated ROS generation assay  as a phototoxic measure was 
performed by analysing a known phototoxic and ROS generator compound, quinine. Taking 
into account Figure 93 it is possible observe a slight increase in fluorescence, only about the 
20% at the maximum time of fluorescence measure up to ~2000 µM. Afterwards, the 
fluorescence begins to decrease until 100%. This decrease correponde to the concentration 
when cell death begins to be significant as can be confirmed by the Figure 73 (section 4.4.4.). 
During apoptosis, cytochrome c is released from mitochondria to the cytosol, which is 
capable to oxidize DCFH directly or indirectly through a peroxidase-type mechanism, 
forming DCF, leading to fluoresence emissions (186). Thus the fluorescence increase 
observed after 2500 µM may be caused by a related phenomenon or others such as ROS 
released with cell death. This increase was more evident in the irradiated plate and 
fluorescence reading at 24h. Therefore, the increase in fluorescence is not sufficiently 
marked, considering quinine is expected to perform as a positive control. Thus, the increase 
of cell density and/or the exposure area (related to width of well) could be tested in future 
studies to allow for a  increase in fluorescence signal. Another explication it the low 
sensitivity of human keratinocytes to quinine HCl mentionated above, thus supporting the 
use of another positive control. 
 
Figure 93. Fluorescence of HaCaT cell line exposed to Quinine HCl by the DCFH-DA assay. +irr= plate 
irradiate. –irr= plate not irradiate. 
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4.4.7. Study of quinine HCL in total glutathione (tGSH)) by DTNB-
GSSG reductase recycling assay with irradiation 
The study of GSH corroborated the previous hypothesis, since GSH production is 
increased in response to oxidative. Thus, the HaCaT exposure to quinine HCl may have 
increased glutathione synthesis, due to powerfull antioxidative system present in 
keratinocytes. It is also noteworthy, although without statistical significative difference, the 
tGSH difference between irradiated and non irradiated plate, suggesting that exposure to 
both UV radiation and quinine HCl may have caused more cell injury (Figure 94).  
 
Figure 94. tGSH of HaCaT cell line exposed to 1260 µM of Quinine HCl normalized by protein using Lowry  
Protocol. +irr= irradiate plate –irr= not irradiate plate. Data are presented as mean ± SD (n=35-69). Data 
were analysed using One-way ANOVA with Dunnett post hoc test. 
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5. Conclusions 
Regulatory authorities demand the photosafety evaluation of pharmaceutical and 
cosmetic products before being placed on the market. Regarding the evaluation of cosmetic 
products or ingredients, testing on animals was banned in Europe since 2009, which 
fostered the development of alternative in vitro methodologies. An in vitro phototoxicity 
test (3T3 NRU-PT) is currently recommended by the OECD and officially accepted by the 
European Union in Directive 2010/63/EU). Among its limitations, the use of a mouse cell 
line and the reports of over-sensitivity are particularly relevant. 
The implementation of the methodology was based on 3T3 NRU-PT but using a human 
keratinocyte cell line (HaCaT), which can represent a more realistic model since these cells 
are abundantly present in the most external layer of skin, where the topical compounds are 
applied, and is also more exposed to solar radiation. 
The HaCaT NRU-PT methodology implemented in this work was based on the official 
test (3T3 NRU-PT) and was optimized with respect to a number of parameters (cell density, 
radiation dose, Neutral Red concentration and incubation time, temperature control) in 
order to obtain a harmonized and robust method. The developed method was validated 
following the phototoxic evaluation of known phototoxic agents and also of non-phototoxic 
compounds. The use of a light source comprising an UVA/UVB Osram lamp is a simple and 
inexpensive choice which has the a benefit of more closely resembling the UV solar 
spectrum in comparison with UVA lamps that are routinely used in photosafety tests. 
The optimized test conditions were defined as follows: UVA/UVB Osram lamp 
positioned at 46.5cm height, 10 min irradiation, cell density of 2x104 cell/well, neutral red 
dye concentration of 50 μg/mL (with 3h incubation time). During the irradiation, the 
temperature achieved in the wells using a water-cooling system varied between 29 and 
32°C, and cell viability was maintained under these conditions.  
 Validation of the HaCaT NRU-PT assay was conducted with three positive controls, 
(CPZ, quinine HCl and 5-MOP) and three negative controls (ASA, hexachlorophene and 
SLS). For all negative controls PIFs were close to 1, while for CPZ and 5-MOP were above 5 
thus confirming the validity of the HaCaT NRU-PT assay developed in this work. 
Noteworthy, for quinine the obtained PIF was not as high as expected. This result may be 
justified by powerful antioxidant system of keratinocytes.  
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The optimized assay was applied to several raw materials of pharmaceutical and cosmetic 
formulations. For 1,2-DHX, avobenzone, diclofenac, H2O2, EHMC, RSV and RGS  no 
phototoxic effects were observed, although in some cases the PIF could not be calculated. 
Only C. sativa extract was shown to be a probable phototoxic agent, presenting a PIF of 2.18 
± 0.42. For future studies, the MPE could be calculated, specially for the test substances for 
which the IC50 values could not be obtained. 
In an attempt to find alternative endpoints and gain mechanistic insight, another 
phototoxicity test was implemented based on stress oxidative markers: ROS generation and 
intracellular glutathione quantification. 
In order to study ROS generation induced by the test compounds using DCFH-DA as 
probe, the cell density, the DCFH-DA concentration and its incubation time were optimized. 
A density of 2x104 cells/well and a concentration of DCFH-DA of 50 µM were considered 
the ideal conditions, since the fluorescence signal was high enough to ensure appropriate 
sensitivity. Regarding the incubation time with the DCFH-DA probe, to decrease the length 
of the assay, a 30 min incubation was chosen for the final procedure. The results showed 
that none of the test compounds led to a marked ROS generation after 24h incubation. In 
the future, a detailed study of these and the fluorescence signal should be carried out. 
 In order to implement a procedure that evaluates ROS generation after irradiation, 
DCFH-DA was tested as a suitable probe and several test conditions were analysed. 
However, this methodology presented high complexity and an optimized procedure could 
not be obtained. As an alternative oxidative stress endpoint we measured intracellular total 
GSH levels, using quinine in an exploratory assay that revealed an increase in tGSH in 
HaCaT cells after quinine incubation. This result allowed us to speculate that the low PIF 
value found with the HaCaT NRU-PT could be due to an adaptive response of keratinocytes 
to oxidative stress. 
In future studies, alternative probes to DCFH-DA and other positive controls should be 
evaluated. A more comprehensive evaluation of tGSH, GSSH and GSH levels after UV 
exposure of known phototoxic agents should also be carried out. The HaCaT NRU-PT 
methodology implemented in this work could be of use to evaluate the phototoxicity of 
potential photosensitizers especially if they are intended for topical application.   
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